[{"text": "Codexis Announces New Employment Inducement Grants Codexis, Inc. Sat, Jan 11, 2025, 12:05 AM 2 min read In This Article: CDXS Codexis, Inc. REDWOOD CITY, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to two new employees as approved by the Compensation Committee of Codexis\u2019 Board of Directors. The newly hired employees received equity awards consisting of an aggregate of (i) options to purchase 23,000 shares of Codexis common stock and (ii) 11,500 restricted stock units (RSUs) as inducement awards under the Company\u2019s 2024 Inducement Plan. The stock options have an exercise price equal to the closing price per share of Codexis\u2019 common stock as reported by Nasdaq on the grant date, and vest over four years, with 25 percent of the shares vesting on the first anniversary of the vesting commencement date, and the remainder vesting ratably at the end of each subsequent month thereafter, subject to each employee\u2019s continued service with Codexis through the applicable vesting dates. The RSUs will vest in equal annual installments on each anniversary of the grant date, until the third anniversary of such date, subject to each employee\u2019s continued service with Codexis through the applicable vesting dates. Codexis is providing this information in accordance with Nasdaq Listing Rule 5635(c)4. About Codexis Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver \u00ae technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule and nucleic acid therapeutics manufacturing. The Company is currently developing its proprietary ECO Synthesis\u2122 manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis\u2019 unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit www.codexis.com . For More Information Investor Contact Carrie McKim (336) 608-9706 ir@codexis.com Media Contact Lauren Musto (650) 421-8205 media@codexis.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2025-01-11T00:05:00", "sentiment": {"score": 0.3882823674939573, "confidence": 0.3959789574146271, "probabilities": {"positive": 0.3959789574146271, "negative": 0.007696589920669794, "neutral": 0.5963244438171387}}, "embedding": [-0.12022947520017624, -0.059810541570186615, -0.09675279259681702, -0.12441292405128479, -0.09762359410524368, 0.007060760632157326, -0.03919791802763939, 0.14584970474243164, 0.06710720807313919, 0.04773876443505287, -0.04782206565141678, 0.09184619784355164, 0.018972238525748253, 0.05372285842895508, -0.09996546804904938, -0.07206553220748901, -0.06216449290513992, 0.08406668156385422, -0.20919176936149597, 0.02774832770228386, 0.1132093220949173, -0.0679149255156517, -0.041672028601169586, -0.05739239975810051, -0.01458914577960968, -0.018108267337083817, -0.07715421169996262, -0.06428951025009155, -0.03764292970299721, -0.03578094393014908, 0.01014886237680912, 0.15246742963790894, 0.047035619616508484, -0.17040936648845673, 0.036440011113882065, 0.10237574577331543, -0.06634464114904404, 0.007711372338235378, -0.06324338912963867, 0.05007875710725784, -0.006009128410369158, 0.02334972284734249, -0.1368866115808487, 0.02857380174100399, -0.20182210206985474, -0.15570992231369019, -0.024374643340706825, 0.010721265338361263, 0.015146023593842983, 0.00434895558282733, -0.17861825227737427, -0.026810063049197197, 0.07185432314872742, 0.001191659364849329, -0.07995796203613281, -0.005169598385691643, -0.06383071094751358, -0.18808895349502563, 0.005741535220295191, -0.051705315709114075, 0.06097564101219177, -0.03380132094025612, -0.01891634240746498, 0.09977366030216217, 0.06025921180844307, 0.06511818617582321, 0.006469577085226774, 0.007121204864233732, -0.01319088414311409, -0.11452776938676834, 0.027332935482263565, -0.03772401064634323, -0.039756156504154205, 0.12071450054645538, 0.04918805509805679, 0.18678461015224457, 0.15966245532035828, 0.014661089517176151, 0.08073917031288147, -0.27861711382865906, -0.07103787362575531, 0.10479533672332764, 0.0030703202355653048, 0.055840782821178436, 0.01338978298008442, 0.15313714742660522, 0.1065436452627182, 0.11559877544641495, 0.21536710858345032, 0.057687245309352875, 0.19354787468910217, -0.052929241210222244, -0.025121038779616356, -0.16556262969970703, -0.06321682780981064, -0.04933132976293564, 0.13520628213882446, -0.009240707382559776, 0.003499506041407585, 0.0479254275560379, -0.02579750306904316, 0.016952387988567352, -0.025860495865345, -0.08915132284164429, -0.13872718811035156, -0.0864187628030777, -0.06467559188604355, 0.0011562369763851166, 0.020054560154676437, -0.11113041639328003, -0.08568060398101807, 0.019564563408493996, -0.004468388855457306, -0.07984212040901184, -0.1156117171049118, 0.15945369005203247, -0.016846731305122375, -0.03290093317627907, 0.18670201301574707, -0.03504321724176407, 0.08615316450595856, -0.04387666657567024, -0.12977302074432373, -0.019912591204047203, 0.001351204700767994, -0.00929982028901577, -0.06605318933725357, 1.084927800816009e-32, -0.07238297164440155, -0.0030660799238830805, -0.00676679564639926, -0.009183283895254135, 0.05271924287080765, -0.1533225178718567, -0.0014001335948705673, 0.003200813662260771, -0.18441466987133026, 0.07167621701955795, -0.16324813663959503, 0.07739231735467911, -0.1028936356306076, 0.10123232007026672, 0.032765451818704605, 0.060466110706329346, 0.020061977207660675, 0.11043219268321991, 0.03988174721598625, 0.021583639085292816, 0.12270286679267883, -0.0018196165328845382, -0.015800530090928078, 0.0665324330329895, 0.10421943664550781, 0.0068410602398216724, -0.037663962692022324, -0.03903093561530113, 0.02408822439610958, 0.042443543672561646, 0.05776023119688034, 0.03849826008081436, -0.0029677506536245346, -0.10173024237155914, -0.028284868225455284, 0.03578288480639458, -0.01124870777130127, -0.03686632588505745, 0.058081164956092834, 0.03876103460788727, 0.055917367339134216, 0.11808497458696365, -0.12681567668914795, -0.08456587046384811, 0.11716154217720032, -0.07725018262863159, 0.005415560211986303, 0.07584920525550842, 0.07969653606414795, 0.07292965054512024, -0.003931140527129173, 0.1453329622745514, 0.16804386675357819, -0.06450323760509491, -0.01569318026304245, 0.044103190302848816, -0.04991375654935837, -0.0913509875535965, 0.12316084653139114, 0.16182829439640045, -0.08031982183456421, 0.05956399440765381, -0.014629142358899117, 0.16624782979488373, -0.08689022064208984, 0.061844225972890854, -0.004672302398830652, -0.1945497989654541, 0.07582445442676544, 0.07939603924751282, -0.12856918573379517, 0.03202053904533386, 0.1699087917804718, -0.03666339069604874, 0.07212261110544205, -0.11829046905040741, 0.06734670698642731, -0.015270387753844261, 0.04563762992620468, -0.015009479597210884, -0.1008441373705864, 0.15115909278392792, -0.1590026319026947, 0.07213063538074493, 0.09276248514652252, -0.0007326286286115646, -0.051890045404434204, 0.06022711098194122, -0.09251589328050613, 0.00025098957121372223, 0.14096185564994812, -0.07862820476293564, -0.11232249438762665, 0.09352897107601166, 0.09753671288490295, -9.576586437572123e-33, 0.02064148709177971, -0.14875459671020508, -0.05366908758878708, -0.07745766639709473, -0.03044828027486801, 0.0741765946149826, -0.014991777017712593, 0.049323126673698425, 0.06969152390956879, -0.030138034373521805, 0.09042108058929443, 0.0904119461774826, -0.05564035475254059, 0.022466016933321953, -0.12730970978736877, 0.003582433797419071, -0.007015862502157688, -0.02576538920402527, -0.039232827723026276, 0.03318890556693077, 0.07363936305046082, 0.2853250503540039, 0.034330449998378754, 0.05871495604515076, 0.19573557376861572, 0.018564680591225624, -0.0334848053753376, 0.2775631248950958, 0.03236832469701767, -0.08637236803770065, -0.05221790820360184, -0.004893936216831207, -0.24465638399124146, 0.03954999893903732, -0.04153958708047867, -0.07696321606636047, 0.09899482131004333, -0.03066944144666195, 0.03470568731427193, 0.04830135405063629, 0.07275081425905228, 0.005081102717667818, 0.015311246737837791, 0.12510541081428528, 0.04397624731063843, 0.004109468311071396, 0.040077440440654755, -0.1068854108452797, 0.17768946290016174, -0.014162806794047356, 0.040214575827121735, -0.09925797581672668, 0.005260815843939781, 0.040987852960824966, 0.061275675892829895, -0.04560106620192528, -0.01505331788212061, -0.03095339424908161, -0.06898294389247894, -0.08069374412298203, 0.0833924412727356, 0.06273314356803894, 0.10938967764377594, 0.06020380184054375, 0.08372792601585388, 0.04095003008842468, -0.013824407942593098, -0.009475390426814556, -0.09598340094089508, -0.049465667456388474, -0.012936926446855068, -0.08851838856935501, 0.10277710855007172, -0.06319386512041092, 0.06598028540611267, 0.058808766305446625, -0.10963587462902069, -0.14350861310958862, -0.1065320372581482, -0.07817971706390381, -0.06703180819749832, 0.037674687802791595, -0.02595839835703373, 0.011880481615662575, 0.018222058191895485, 0.14740166068077087, 0.06567875295877457, 0.06629370898008347, -0.013577965088188648, 0.02396988682448864, -0.1092570573091507, -0.10360750555992126, -0.022858815267682076, 0.1452300101518631, 0.04993145912885666, -1.0019948604167439e-07, 0.09021815657615662, -0.004055822268128395, -0.15753678977489471, -0.11699164658784866, -0.01129226479679346, -0.151708722114563, 0.0319657027721405, 0.04116874560713768, 0.031776152551174164, 0.011100351810455322, 0.20939436554908752, 0.19178469479084015, -0.028970522806048393, 0.028455886989831924, -0.05472198873758316, 0.06879240274429321, -0.1241031289100647, -0.06338376551866531, -0.16639544069766998, -0.17901691794395447, 0.0552423819899559, 0.07062754034996033, 0.07777760177850723, -0.016687795519828796, 0.029912743717432022, -0.09985735267400742, 0.04086558520793915, 0.06956791877746582, 0.03569863736629486, -0.04766303673386574, 0.03695080429315567, -0.06702083349227905, 0.06331086903810501, 0.061855629086494446, 0.057113826274871826, -0.06018734723329544, -0.09927152842283249, 0.08366239815950394, 0.019468750804662704, 0.033049117773771286, 0.01604558154940605, -0.11508768796920776, -0.09645789116621017, -0.016488410532474518, -0.003796188859269023, 0.0011737477034330368, -0.23875389993190765, 0.04325271397829056, 0.05807407200336456, -0.13288122415542603, -0.020395228639245033, -0.0573301799595356, -0.005321529693901539, -0.009977726265788078, -0.0668737143278122, 0.09943059086799622, -0.06922353804111481, -0.046015650033950806, 0.012148970738053322, -0.09451092779636383, 0.0012234970927238464, -0.10914869606494904, 0.10023366659879684, -0.007924399338662624], "changes": {"1wk": 13.895219864841103}}, {"text": "Codexis Appoints Christos Richards to Board of Directors Codexis, Inc. Fri, Jan 17, 2025, 12:05 AM 5 min read In This Article: CDXS Codexis, Inc. Christos Richards Christos Richards appointed to Codexis Board of Directors. REDWOOD CITY, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Christos Richards to the Company\u2019s Board of Directors. \u201cI am delighted to welcome Christos to our Board. His broad and deep knowledge and understanding of the life sciences industry will be invaluable as we continue the transformation of Codexis,\u201d said Stephen Dilly, MBBS, PhD, Chairman and Chief Executive Officer at Codexis. Mr. Richards added, \u201cAs a longstanding partner to the biopharmaceutical industry, I\u2019m well aware of the potential of Codexis\u2019 proprietary technologies and their ability to enable the exponential expansion of RNAi therapeutics and other novel therapeutic modalities. I\u2019m thrilled to partner with the management team and Board of Directors to see the company through this next phase of growth.\u201d Christos Richards brings over 30 years of global executive advisory and search experience for the biopharmaceutical and healthcare industry to Codexis. To date, he has completed more than 450 executive level assignments, including over 200 Board, CEO and CEO succession projects in the Life Sciences sector. He currently serves as Global Head of Healthcare and Life Sciences at Calibre One, a global executive search firm with offices across California as well as Chicago, New York and London. Mr. Richards serves clients from venture-backed startups to leading global enterprises in devices, diagnostics, agricultural biotechnology, animal health, tools, services and digital health sectors. He has spent 20 years as a partner with two prominent boutique search firms, including serving as Chief Executive Officer of Levin & Company. Mr. Richards previously served on the Board of Directors for Coherus BioSciences and is also an advisor for the University of California, San Francisco Innovation Ventures Entrepreneurship Center. He holds a diploma in hospitality management from Schweizerische Wirteschule in Lucerne/Davos, Switzerland. About Codexis Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver \u00ae technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis\u2122 manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis\u2019 unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com . Story Continues Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as \u201caim,\u201d \u201canticipate,\u201d \u201cassume,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cdesign,\u201d \u201cdue,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cgoal,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cobjective,\u201d \u201cplan,\u201d \u201cpositioned,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201csuggest,\u201d \u201ctarget,\u201d \u201con track,\u201d \u201cwill,\u201d \u201cwould\u201d and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management, including but not limited to statements regarding the potential of the ECO Synthesis\u2122 platform, and it providing an opportunity for Codexis to efficiently capture meaningful market share; expectations regarding Codexis meeting its technical and commercial milestones regarding the ECO Synthesis\u2122 platform; and expectations regarding the potential of and future demand for RNAi therapeutics, and whether Codexis will be able to capitalize on such demand. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Codexis\u2019 control and that could materially affect actual results. Factors that could materially affect actual results include, among others: Codexis\u2019 dependence on its licensees and collaborators; if any of its collaborators terminate their development programs under their respective license agreements with Codexis; Codexis may need additional capital in the future in order to expand its business; if Codexis is unable to successfully develop and commercialize new technology such as its ECO Synthesis\u2122 platform and its dsRNA ligase; Codexis dependence on a limited number of products and customers, and potential adverse effects to Codexis\u2019 business if its customers\u2019 products are not received well in the markets; if competitors and potential competitors who have greater resources and experience than Codexis develop products and technologies that make Codexis\u2019 products and technologies obsolete; if Codexis is unable to accurately forecast financial and operational performance; and market and economic conditions may negatively impact Codexis business, financial condition and share price. Additional information about factors that could materially affect actual results can be found in Codexis\u2019 Annual Report on Form 10-K filed with the Securities and Exchange Commission (\u201cSEC\u201d) on February 28, 2024 and in Codexis\u2019 Quarterly Report on Form 10-Q filed with the SEC on October 31, 2024, including under the caption \u201cRisk Factors,\u201d and in Codexis\u2019 other periodic reports filed with the SEC. Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. For More Information Investor Contact Carrie McKim (336) 608-9706 ir@codexis.com Media Contact Lauren Musto (650) 421-8205 media@codexis.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d91e0c61-c7d9-42da-988e-c319b16f9fc0 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2025-01-17T00:05:00", "sentiment": {"score": 0.16922591160982847, "confidence": 0.17833641171455383, "probabilities": {"positive": 0.17833641171455383, "negative": 0.009110500104725361, "neutral": 0.8125531077384949}}, "embedding": [-0.06219939514994621, -0.1072431281208992, -0.12902593612670898, -0.11572083830833435, 0.02903030440211296, -0.09247944504022598, -0.022547177970409393, 0.08145572990179062, 0.1239061951637268, 0.05027906596660614, -0.19563253223896027, 0.0323294959962368, 0.00043491553515195847, 0.10154104977846146, -0.13589665293693542, -0.0926780253648758, -0.10674451291561127, -0.0015990184620022774, -0.13035020232200623, 0.04455147683620453, 0.08058230578899384, 0.013988517224788666, 0.008199837058782578, -0.11788369715213776, -0.12469776719808578, 0.016459565609693527, -0.13007116317749023, -0.1557522863149643, -0.1936558187007904, -0.045928020030260086, 0.05295531079173088, 0.16663962602615356, 0.039845697581768036, -0.1119055226445198, 0.005060612689703703, 0.19059813022613525, 0.054196566343307495, -0.0019854300189763308, -0.07011425495147705, 0.007562245242297649, 0.050733305513858795, 0.028341185301542282, -0.12130711227655411, 0.004685571882873774, -0.09398943185806274, -0.20566622912883759, 0.03388892859220505, -0.12546101212501526, 0.0505799725651741, -0.05926712602376938, -0.28476041555404663, -0.11633811891078949, 0.11461912095546722, -0.018690936267375946, -0.11886514723300934, 0.11296281218528748, 0.003838103264570236, -0.18803972005844116, 0.03154798597097397, -0.11237027496099472, 0.04727170988917351, -0.020992428064346313, 0.055517107248306274, 0.1440516859292984, 0.10035938769578934, 0.06586748361587524, -0.03319872170686722, -0.008330471813678741, -0.13235610723495483, -0.08614825457334518, 0.02046990767121315, -0.09157463163137436, -0.014179492369294167, 0.13908877968788147, 0.11492767184972763, 0.12040382623672485, 0.11835775524377823, 0.0727134644985199, 0.1556275486946106, -0.2195606231689453, 0.08134466409683228, 0.03031018376350403, -0.06238691508769989, 0.10228071361780167, -0.09945853054523468, 0.11677855998277664, 0.03907855227589607, 0.06542104482650757, 0.10662420839071274, 0.04327967390418053, 0.15300151705741882, -0.09063773602247238, 0.09125427901744843, -0.0767870545387268, -0.10363159328699112, -0.05747246742248535, 0.13713666796684265, 0.015592984855175018, 0.015433991327881813, 0.024255163967609406, -0.14827370643615723, -0.021642427891492844, 0.06486418843269348, 0.03214383125305176, -0.13859057426452637, -0.07486743479967117, -0.060158707201480865, 0.04542246833443642, 0.12037092447280884, -0.0328427255153656, -0.08373790979385376, 0.09729038178920746, -0.04355929419398308, -0.02024039439857006, 0.0031279949471354485, 0.010885576717555523, -0.05726003646850586, 0.04486025497317314, 0.14931103587150574, -0.035890474915504456, 0.03705894947052002, 0.025623373687267303, -0.11058691143989563, -0.08936747908592224, 0.05720200389623642, 0.06133800745010376, -0.0655098706483841, 7.428790015990842e-33, 0.05473370477557182, 0.1120547354221344, 0.10065130889415741, 0.012040544301271439, 0.041288137435913086, -0.08231385797262192, 0.02852228656411171, 0.04766201227903366, -0.09797649085521698, -0.027008431032299995, -0.12537476420402527, 0.14209844172000885, -0.0975160151720047, 0.13077443838119507, -0.07018648087978363, 0.1342591941356659, -0.018436115235090256, -0.014253251254558563, -0.04165994003415108, -0.06753743439912796, 0.04903165251016617, 0.004811610095202923, -0.05840916559100151, 0.10793036222457886, 0.12306801974773407, 0.03542623668909073, -0.04060429707169533, 0.03507406637072563, 0.06285541504621506, 0.0628717690706253, -0.03460199385881424, 0.06604307889938354, -0.05118261277675629, -0.08927598595619202, 0.06258003413677216, 0.0283762626349926, -0.04140280932188034, -0.01631600596010685, 0.0818832665681839, 0.057752035558223724, -0.007580538280308247, 0.1213308572769165, -0.08821243047714233, -0.0067665791139006615, 0.00028710998594760895, -0.004056944977492094, 0.09813342988491058, 0.0533623993396759, 0.18611955642700195, 0.026619717478752136, -0.049419745802879333, 0.013678351417183876, 0.1575884073972702, 0.0009842943400144577, 0.07242362201213837, 0.031817760318517685, -0.0423269048333168, -0.051288582384586334, 0.11587177217006683, 0.1286008656024933, -0.09100832045078278, 0.08511027693748474, -0.005851522088050842, 0.19261810183525085, -0.03366710990667343, -0.00671729352325201, 0.011524795554578304, -0.13413697481155396, 0.07508013397455215, -0.0068351151421666145, -0.13742400705814362, 0.053429294377565384, 0.1973591446876526, 0.006796571426093578, -0.03324660286307335, -0.05879845470190048, -0.027243852615356445, -0.05237665772438049, -0.06852047890424728, 0.06429161876440048, -0.009696399793028831, 0.12704172730445862, -0.10823553055524826, 0.019494343549013138, 0.05024050921201706, 0.012910982593894005, -0.01802518218755722, -0.03219848871231079, -0.09486476331949234, 0.034579820930957794, -0.009120475500822067, -0.10944966971874237, 0.007866425439715385, 0.049818914383649826, -0.023860778659582138, -9.800622436527404e-33, -0.012182098813354969, -0.21595878899097443, -0.019151192158460617, -0.09725285321474075, 0.006644967943429947, 0.024789297953248024, 0.024144619703292847, 0.050497982650995255, 0.11481061577796936, -0.17511418461799622, 0.07085134088993073, 0.13975432515144348, 0.001371806487441063, -0.0005745925009250641, -0.10864393413066864, 0.04389188438653946, -0.02489192597568035, -0.05247664824128151, -0.14292989671230316, -0.03740797936916351, 0.08438742905855179, 0.19191953539848328, -0.041093431413173676, 0.02866140753030777, 0.1463296264410019, 0.026150915771722794, -0.020019927993416786, 0.17896994948387146, -0.020215582102537155, -0.06356565654277802, -0.02527529001235962, 0.08708247542381287, -0.18850216269493103, -0.011227134615182877, -0.01619558408856392, -0.01300550065934658, -0.038265105336904526, -0.05898195877671242, 0.05469324439764023, 0.01577712409198284, 0.0953812301158905, -0.019472898915410042, -0.007577523589134216, -0.0007302723824977875, 0.0607038214802742, 0.06697200238704681, -0.019075073301792145, -0.043115586042404175, 0.07762860506772995, 0.07357756793498993, -0.06591732800006866, 0.0012061987072229385, -0.10327694565057755, -0.020560050383210182, 0.10067355632781982, -0.027965087443590164, -0.02474593184888363, 0.02733903005719185, -0.10094636678695679, -0.10257384181022644, 0.08310553431510925, 0.10153116285800934, 0.15273918211460114, 0.07435302436351776, 0.016598878428339958, 0.09096229076385498, 0.04342249780893326, -0.0060765091329813, -0.052788883447647095, -0.06135125458240509, -0.02391371876001358, -0.12060922384262085, -0.0034171268343925476, -0.10014596581459045, -0.015034019947052002, 0.08574739843606949, -0.19883042573928833, -0.21499645709991455, -0.16048142313957214, -0.04315982013940811, 0.007573547773063183, -0.0032648779451847076, 0.00020353589206933975, 0.03147263824939728, 0.06348834931850433, 0.1587948501110077, 0.029334785416722298, -0.0975063294172287, -0.033419232815504074, -0.038163624703884125, -0.09560121595859528, -0.20653755962848663, -0.07781867682933807, 0.03761664032936096, 0.05026458948850632, -1.0071785538912081e-07, 0.08826473355293274, 0.019617583602666855, -0.09456240385770798, -0.10355968773365021, -0.050215721130371094, -0.07732664048671722, 0.0028338534757494926, 0.025433743372559547, 0.07351222634315491, 0.09545030444860458, 0.1538238674402237, 0.13789322972297668, -0.023456742987036705, 0.05893336981534958, 0.031767524778842926, 0.07794022560119629, -0.09572610259056091, -0.002783762291073799, -0.1474502980709076, -0.07770666480064392, 0.06570446491241455, 0.08019053936004639, 0.07638280093669891, -0.008133018389344215, 0.12472783029079437, -0.16027146577835083, -0.022131429985165596, -0.0724363774061203, -0.021709244698286057, 0.002103785052895546, 0.00046033645048737526, -0.05054512992501259, -0.028935100883245468, 0.14173904061317444, 0.13955117762088776, -0.13144592940807343, -0.07036144286394119, 0.055911220610141754, -0.015326329506933689, 0.07274894416332245, 0.012628154829144478, -0.03760458528995514, -0.09624826908111572, 0.08395040780305862, -0.0728159248828888, -0.06588373333215714, -0.12491278350353241, 0.1569417268037796, 0.11205019056797028, -0.11411430686712265, -0.05132361873984337, 0.00439319247379899, -0.047831613570451736, -0.04489631950855255, -0.0981748104095459, 0.10250192135572433, 0.02039457857608795, 0.004043602384626865, -0.0960715264081955, -0.030111249536275864, 0.024079352617263794, -0.19004669785499573, 0.1405491828918457, -0.01423650048673153], "changes": {"1wk": 1.2195110131936575}}, {"text": "PREMIUM Caribou Biosciences Names Sri Ryali CFO MT Newswires Thu, Jan 2, 2025, 4:45 PM In This Article: CRBU CDXS Caribou Biosciences (CRBU) said Thursday it has appointed Sri Ryali as chief financial officer. R PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2025-01-02T16:45:55", "sentiment": {"score": 0.03892250079661608, "confidence": 0.05182959511876106, "probabilities": {"positive": 0.05182959511876106, "negative": 0.012907094322144985, "neutral": 0.9352633357048035}}, "embedding": [-0.1376664787530899, -0.07675819098949432, -0.05132511258125305, -0.005707265343517065, 0.05789925530552864, 0.10352013260126114, -0.011590439826250076, 0.09436465799808502, -0.14141394197940826, 0.028276653960347176, -0.045870229601860046, -0.11225908994674683, 0.019992666319012642, 0.062008943408727646, -0.12437447905540466, -0.09487725049257278, 0.04387154057621956, -0.03678865358233452, 0.13215136528015137, -0.04188142716884613, -0.14531022310256958, -0.0003776589874178171, -0.03312529996037483, -0.03206474706530571, 0.05770355463027954, -0.037596091628074646, -0.17849427461624146, 0.04661640152335167, -0.011760272085666656, -0.0053529273718595505, 0.11348073929548264, 0.09176766872406006, 0.0914958193898201, -0.132380411028862, 0.13645781576633453, 0.032903365790843964, -0.13935118913650513, -0.04425256699323654, -0.01185886561870575, 0.008306053467094898, 0.013628928922116756, -0.12461281567811966, 0.044169072061777115, 0.033412639051675797, -0.03827054053544998, -0.07110481709241867, 0.13135488331317902, -0.045689430087804794, 0.05752074345946312, -0.05157988891005516, -0.20559275150299072, -0.21269266307353973, 0.02920786291360855, -0.06972099095582962, 0.0024810247123241425, 0.11731738597154617, -0.013712952844798565, -0.0973426029086113, 0.026543425396084785, -0.21789433062076569, -0.03075200505554676, -0.05277693271636963, -0.05525585263967514, 0.15056651830673218, 0.05739717558026314, -0.033686794340610504, -0.11630687117576599, 0.08922255039215088, 0.08700645714998245, -0.026330070570111275, 0.05253247544169426, 0.03098207525908947, 0.026495229452848434, 0.022520214319229126, 0.03112470917403698, 0.24090130627155304, 0.014659158885478973, 0.10819417983293533, 0.150193989276886, -0.08723600953817368, 0.009845674969255924, -0.049658071249723434, 0.08470090478658676, -0.1324649602174759, 0.0026795747689902782, 0.09726358205080032, 0.1665654480457306, -0.17841553688049316, -0.07126843929290771, -0.09752294421195984, 0.33462318778038025, -0.08007127046585083, 0.12982454895973206, -0.06437437236309052, -0.2661915123462677, -0.0373508483171463, -0.04120149090886116, -0.08027075976133347, -0.07485119998455048, -0.04876318946480751, -0.09134629368782043, 0.08143927901983261, -0.12463220208883286, 0.10920260101556778, -0.13719944655895233, -0.04082559421658516, -0.18899483978748322, 0.16520331799983978, 0.055105116218328476, 0.058148786425590515, -0.15681825578212738, 0.2174140214920044, -0.0944148451089859, -0.05462149530649185, -0.11426230520009995, 0.16331015527248383, -0.18179374933242798, 0.06428828835487366, 0.08082303404808044, -0.057520557194948196, -0.02473875880241394, -0.03091323934495449, -0.15713223814964294, -0.14026257395744324, 0.09465650469064713, 0.02205427922308445, -0.1507892906665802, 1.6755974021200908e-32, 0.08619096130132675, 0.17436252534389496, 0.13295269012451172, -0.11757563799619675, 0.08093035221099854, -0.00830571074038744, -0.1961430013179779, -0.132229283452034, -0.015532460063695908, 0.0010041560744866729, -0.12991373240947723, 0.13303403556346893, 0.07501742243766785, 0.01645555905997753, -0.25890105962753296, -0.014076456427574158, -0.2160852551460266, 0.05395437031984329, -0.09392628073692322, 0.039905332028865814, 0.05579685792326927, 0.09711219370365143, 0.08595985919237137, 0.09853564947843552, 0.058842629194259644, 0.05156872421503067, 0.1928970366716385, 0.023216139525175095, 0.15194790065288544, 0.21804441511631012, 0.009736085310578346, -0.09197606146335602, -0.0962812528014183, -0.038617171347141266, 0.14221660792827606, -0.05436267703771591, -0.11148746311664581, -0.16942743957042694, -0.057095881551504135, 0.1373264491558075, 0.15538309514522552, -0.04266145080327988, -0.1615280956029892, 0.03729208558797836, 0.01108289323747158, -0.11597183346748352, 0.16612881422042847, 0.04230369254946709, 0.1705552488565445, -0.05186113342642784, -0.10375236719846725, -0.01816992461681366, -0.036768838763237, -0.03603127598762512, 0.11381461471319199, 0.0327814444899559, -0.021179459989070892, -0.10764482617378235, 0.05355694144964218, -0.05095074698328972, 0.06304167956113815, 0.1424892246723175, -0.03360309824347496, -0.07403907179832458, -0.033999595791101456, 0.025407619774341583, -0.07033833116292953, -0.23113401234149933, 0.18365028500556946, -0.017289334908127785, 0.08222512155771255, -0.08466292172670364, 0.14705204963684082, 0.04918800666928291, -0.030194206163287163, 0.02736710011959076, 0.05192388594150543, 0.03547774627804756, -0.07049120217561722, 0.0781809538602829, -0.04480340704321861, 0.1217634454369545, 0.16329485177993774, 0.022834695875644684, 0.1473802775144577, -0.13534145057201385, -0.1354709416627884, -0.07912040501832962, 0.057222880423069, 0.08308631926774979, -0.009726332500576973, 0.012235048227012157, 0.02774818055331707, 0.164603129029274, -0.15388906002044678, -1.554768190862274e-32, -0.073678158223629, -0.09117814153432846, 0.0638057217001915, 0.006705362815409899, -0.06907933950424194, -0.0192429032176733, -0.05354386568069458, 0.05265820398926735, 0.2670207619667053, -0.10127830505371094, 0.1034020259976387, 0.157701313495636, -0.058501437306404114, -0.08240373432636261, 0.1847473382949829, 0.12925954163074493, 0.07901942729949951, -0.10244215279817581, -0.29981333017349243, 0.041151437908411026, -0.03520308807492256, 0.020919881761074066, -0.011059727519750595, 0.15180155634880066, 0.2040061205625534, 0.051315516233444214, 0.15819557011127472, 0.11423216760158539, 0.06150892376899719, -0.04965776577591896, -0.06834502518177032, -0.07154698669910431, -0.3311292231082916, 0.13359783589839935, -0.14383505284786224, -0.024368099868297577, 0.1053241714835167, 0.059508442878723145, -0.04951784014701843, 0.2471829354763031, 0.17599591612815857, 0.03156309947371483, -0.08247382938861847, -0.058022309094667435, -0.018965203315019608, -0.25253787636756897, -0.09351231902837753, 0.01951434090733528, 0.09772989898920059, -0.010277541354298592, -0.07388150691986084, -0.07707709074020386, 0.01646139845252037, -0.014899485744535923, 0.10098950564861298, 0.07488137483596802, 0.05962968245148659, 0.13154000043869019, 0.08987526595592499, 0.11124502867460251, 0.2218056172132492, 0.1605719029903412, -0.09388040751218796, 0.009922124445438385, 0.04567362740635872, 0.13605059683322906, 0.1544664204120636, -0.08127632737159729, 0.024144940078258514, -0.13600757718086243, 0.1551584154367447, -0.04617203399538994, -0.04481158033013344, -0.10753770172595978, -0.002367375884205103, 0.17029525339603424, -0.3414224684238434, -0.05442710220813751, -0.20168648660182953, 0.06381630897521973, 0.09299250692129135, -0.07237423956394196, 0.01268095150589943, 0.01565738394856453, 0.07208237797021866, -0.04031657427549362, -0.08746568113565445, -0.1384953260421753, 0.10656667500734329, -0.040492940694093704, -0.04671993851661682, -0.20361845195293427, -0.0914883241057396, 0.21374008059501648, 0.19756530225276947, -9.965724956373379e-08, 0.18297775089740753, -0.16770882904529572, 0.016251716762781143, -0.0463162399828434, 0.14692266285419464, -0.048788879066705704, -0.10952544957399368, -0.1324165314435959, -0.014426223002374172, 0.1342839002609253, 0.08461203426122665, -0.016753584146499634, 0.08268977701663971, 0.010039697401225567, 0.05343278869986534, 0.07773012667894363, 0.014405561611056328, 0.11577087640762329, -0.14440980553627014, 0.04144847020506859, -0.0028203243855386972, 0.08450211584568024, 0.09404389560222626, -0.07458557188510895, 0.031160052865743637, -0.17193293571472168, 0.03970114141702652, 0.018319448456168175, -0.03714294731616974, -0.004720843862742186, -0.07669012248516083, 0.09964881092309952, -0.02976546436548233, -0.014902914874255657, -0.05325346067547798, 0.04426763579249382, 0.09538215398788452, 0.06992269307374954, -0.02831265516579151, 0.07519861310720444, -0.0532311350107193, -0.0009408250916749239, 0.08429113030433655, 0.1296897977590561, -0.10460438579320908, 0.08166579902172089, -0.06384383887052536, -0.022823909297585487, 0.004669364541769028, -0.14191018044948578, 0.03807637840509415, -0.03655902296304703, -0.05010751262307167, 0.046146657317876816, -0.08478185534477234, 0.10065118968486786, -0.05815751850605011, -0.12103273719549179, -0.14753654599189758, -0.07452991604804993, -0.13325075805187225, -0.19640399515628815, 0.19216634333133698, -0.08396080136299133], "changes": {"1wk": -4.799995422363281, "1mo": -16.19999885559082}}, {"text": "Is There An Opportunity With Codexis, Inc.'s (NASDAQ:CDXS) 22% Undervaluation? editorial-team@simplywallst.com (Simply Wall St) Fri, Jan 10, 2025, 3:31 PM 6 min read In This Article: CDXS Key Insights Codexis' estimated fair value is US$6.07 based on 2 Stage Free Cash Flow to Equity Codexis' US$4.76 share price signals that it might be 22% undervalued Our fair value estimate is 19% lower than Codexis' analyst price target of US$7.50 How far off is Codexis, Inc. ( NASDAQ:CDXS ) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine. Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model . See our latest analysis for Codexis Step By Step Through The Calculation We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars: 10-year free cash flow (FCF) forecast 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF ($, Millions) -US$34.7m -US$20.6m -US$8.75m -US$15.5k US$6.54m US$11.2m US$16.8m US$22.9m US$28.9m US$34.4m Growth Rate Estimate Source Analyst x2 Analyst x2 Analyst x2 Analyst x2 Analyst x2 Est @ 71.05% Est @ 50.52% Est @ 36.15% Est @ 26.09% Est @ 19.05% Present Value ($, Millions) Discounted @ 6.5% -US$32.6 -US$18.1 -US$7.2 -US$0.01 US$4.8 US$7.7 US$10.8 US$13.8 US$16.4 US$18.3 (\"Est\" = FCF growth rate estimated by Simply Wall St) Present Value of 10-year Cash Flow (PVCF) = US$14m Story Continues After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.6%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 6.5%. Terminal Value (TV) = FCF 2034 \u00d7 (1 + g) \u00f7 (r \u2013 g) = US$34m\u00d7 (1 + 2.6%) \u00f7 (6.5%\u2013 2.6%) = US$904m Present Value of Terminal Value (PVTV) = TV / (1 + r) 10 = US$904m\u00f7 ( 1 + 6.5%) 10 = US$480m The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is US$494m. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of US$4.8, the company appears a touch undervalued at a 22% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. NasdaqGS:CDXS Discounted Cash Flow January 10th 2025 Important Assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Codexis as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.5%, which is based on a levered beta of 0.948. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. SWOT Analysis for Codexis Strength Debt is well covered by earnings. Weakness Shareholders have been diluted in the past year. Opportunity Forecast to reduce losses next year. Trading below our estimate of fair value by more than 20%. Threat Debt is not well covered by operating cash flow. Has less than 3 years of cash runway based on current free cash flow. Not expected to become profitable over the next 3 years. Next Steps: Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price sitting below the intrinsic value? For Codexis, we've compiled three fundamental items you should explore: Risks : For example, we've discovered 2 warning signs for Codexis that you should be aware of before investing here. Future Earnings : How does CDXS's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart . Other Solid Businesses : Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NASDAQGS every day. If you want to find the calculation for other stocks just search here . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2025-01-10T15:31:23", "sentiment": {"score": -0.08199571818113327, "confidence": 0.12971290946006775, "probabilities": {"positive": 0.04771719127893448, "negative": 0.12971290946006775, "neutral": 0.8225699067115784}}, "embedding": [-0.07632258534431458, -0.053584735840559006, -0.07177270203828812, -0.017686601728200912, 0.021731635555624962, -0.03443190082907677, -0.017521105706691742, 0.14276814460754395, 0.16531896591186523, 0.09963268041610718, -0.08927586674690247, -0.005730761215090752, 0.04097793251276016, -0.007975725457072258, -0.03203142061829567, -0.14798706769943237, -0.042437098920345306, 0.07118778675794601, -0.18835999071598053, 0.028535926714539528, 0.03912307322025299, -0.13553006947040558, -0.04287946969270706, -0.06596218049526215, -0.010202661156654358, -0.06446074694395065, -0.04737534373998642, -0.05617544800043106, -0.027536945417523384, -0.05051807314157486, 0.0558549240231514, 0.1705145239830017, 0.10432538390159607, -0.10397984087467194, 0.015497911721467972, -0.0046212682500481606, 0.07314018905162811, 0.15269538760185242, 0.015122119337320328, 0.08406795561313629, -0.02625357173383236, 0.04524010047316551, -0.01085050031542778, -0.0009083105251193047, 0.007293215021491051, -0.18242859840393066, 0.062496863305568695, -0.02724429965019226, -0.027866601943969727, 0.017537709325551987, -0.10317541658878326, 0.15014132857322693, 0.025187063962221146, 0.021374018862843513, -0.04351583868265152, 0.07802393287420273, -0.012865010648965836, -0.21951864659786224, 0.0310998372733593, -0.09243849664926529, -0.022412411868572235, -0.054346758872270584, 0.061671044677495956, 0.0903761237859726, 0.08562106639146805, 0.07824337482452393, -0.04416213184595108, 0.05968766286969185, -0.14771831035614014, -0.04925265535712242, -0.052551232278347015, -0.018062498420476913, -0.08819884806871414, -0.08057669550180435, 0.02732217125594616, 0.10606088489294052, 0.13529719412326813, 0.03807736188173294, 0.10035914182662964, -0.1701638400554657, 0.10865509510040283, 0.09959333389997482, -0.03711700066924095, -0.06176032871007919, -0.05314338952302933, 0.09983190149068832, 0.13649386167526245, 0.011519288644194603, 0.11282835900783539, 0.00118242297321558, 0.1581490933895111, 0.00031630194280296564, -0.17312821745872498, -0.0300042275339365, 0.08572163432836533, -0.028948228806257248, 0.05433771386742592, -0.051424864679574966, 0.0013170521706342697, 0.13002906739711761, 0.03637828305363655, 0.028174379840493202, 0.05324745923280716, -0.037277769297361374, -0.08779308944940567, -0.13291701674461365, 0.00637438427656889, 0.06581941246986389, -0.022869113832712173, -0.0381472110748291, -0.006616669707000256, 0.032636165618896484, -0.04032905027270317, -0.02075621485710144, 0.03673280030488968, -0.058884307742118835, -0.012777229771018028, -0.075321726500988, 0.11076188832521439, -0.09617041051387787, 0.011561885476112366, 0.02131938561797142, -0.06776748597621918, 0.1436859369277954, -0.038766033947467804, -0.011093730106949806, -0.0659310519695282, 1.0029738040446176e-32, -0.15844550728797913, 0.0741119384765625, 0.046655550599098206, -0.18872836232185364, 0.012503590434789658, -0.13016855716705322, 0.02888205274939537, -0.020187996327877045, -0.017856022343039513, 0.07962644845247269, -0.04348968341946602, 0.14167910814285278, -0.13445860147476196, -0.028873499482870102, -0.032342251390218735, 0.04419559985399246, -0.11530786752700806, -0.016553275287151337, 0.06490593403577805, -0.05575397610664368, 0.10065466165542603, 0.009570933878421783, 0.03535521402955055, -0.017130795866250992, 0.10375455766916275, -0.04504905641078949, -0.0623052716255188, 0.04581035301089287, -0.08124088495969772, 0.03185289353132248, 0.019160736352205276, 0.03404618799686432, -0.02223418466746807, -0.11987509578466415, -0.009714270010590553, -0.005584266036748886, -0.016171468421816826, 0.019578997045755386, 0.026538582518696785, -0.05953541398048401, -0.0696273073554039, 0.11533362418413162, -0.07841069996356964, -0.046986985951662064, -0.06291133165359497, -0.092523954808712, 0.07273567467927933, -0.05168338119983673, 0.062116898596286774, 0.04462943226099014, 0.05908803641796112, 0.03314675763249397, -0.11012768000364304, -0.10162632167339325, -0.0786081999540329, 0.0646069347858429, -0.037815291434526443, -0.12600068747997284, 0.02427038364112377, 0.22960707545280457, -0.09604474902153015, 0.019764306023716927, -0.05631864070892334, -0.018358366563916206, -0.16590158641338348, 0.17703652381896973, -0.07471702247858047, 0.02741733007133007, 0.11872656643390656, -0.052269116044044495, -0.019410300999879837, 0.043235406279563904, 0.10768935829401016, -0.048240020871162415, 0.042710691690444946, -0.02745164930820465, 0.07461504638195038, -0.011901102028787136, 0.06018073856830597, 0.036714859306812286, -0.14832615852355957, 0.03467662259936333, -0.03698991611599922, 0.035423643887043, 0.041124455630779266, -0.08113539218902588, 0.04101836681365967, 0.007999598979949951, -0.052238866686820984, -0.060912903398275375, 0.038265079259872437, -0.05315454304218292, -0.07257193326950073, 0.09962570667266846, 0.07481075823307037, -1.241805750393699e-32, 0.024903498589992523, -0.026347937062382698, -0.027643006294965744, 0.03832982853055, 0.026556698605418205, -0.04075492173433304, 0.014569805935025215, 0.11815641075372696, 0.059026557952165604, -0.16028043627738953, -0.016175925731658936, 0.13488143682479858, -0.08691221475601196, 0.12868420779705048, 0.03951602429151535, -0.0805400013923645, 0.08341777324676514, -0.07913254201412201, 0.016099950298666954, 0.1086222231388092, 0.04495437815785408, 0.12638543546199799, -0.12476727366447449, 0.04683837294578552, 0.03754891827702522, 0.03922749683260918, -0.059875935316085815, 0.11431370675563812, -0.05245339870452881, -0.045313891023397446, -0.01691906712949276, 0.03143856301903725, -0.10396823287010193, -0.0027935178950428963, -0.0724979043006897, -0.08449695259332657, 0.003792649833485484, -0.045290257781744, -0.0756663829088211, 0.033375274389982224, 0.036016836762428284, 0.020837562158703804, -0.04877820611000061, -0.03855006396770477, 0.056153904646635056, 0.08569484949111938, 0.09422217309474945, 0.03061569109559059, 0.18792589008808136, 0.035822439938783646, 0.10179321467876434, -0.011757808737456799, -0.014990835450589657, 0.0998760312795639, -0.14456355571746826, 0.0770457312464714, 0.03708534315228462, -0.001585626509040594, -0.025356456637382507, 0.009519360959529877, 0.07010237127542496, 0.09394055604934692, -0.03988189250230789, 0.01897297240793705, 0.02364804781973362, 0.006949233822524548, -0.09596248716115952, -0.10000114887952805, -0.05489201843738556, -0.034560415893793106, -0.007780604064464569, -0.06847803294658661, 0.07411783933639526, -0.02899309992790222, 0.040490686893463135, 0.08229613304138184, -0.07512171566486359, -0.13309724628925323, -0.0028500857297331095, -0.007668222300708294, -0.11639940738677979, 0.10259315371513367, -0.021890789270401, -0.05258838087320328, -0.16186071932315826, 0.08669711649417877, -0.013820483349263668, -0.12155213952064514, -0.15026389062404633, 0.0274217389523983, -0.13755600154399872, -0.09680690616369247, -0.053579531610012054, -0.03551546484231949, -0.024251600727438927, -1.0025157592963296e-07, -0.057888422161340714, 0.004018249921500683, -0.02322119101881981, -0.016572244465351105, -0.011341530829668045, -0.08758828043937683, 0.06852386891841888, -0.07389770448207855, 0.08942718058824539, 0.02515358477830887, 0.24986179172992706, 0.09548957645893097, -0.05290999636054039, 0.0106327123939991, -0.12813284993171692, 0.10489814728498459, -0.05821901559829712, -0.031756091862916946, -0.0303910244256258, -0.049458205699920654, 0.07687298208475113, 0.09461113810539246, 0.06879165768623352, -0.057576701045036316, 0.06487181782722473, -0.13539354503154755, -0.047025054693222046, 0.04436177387833595, -0.0224299393594265, 0.013916054740548134, 0.06369446963071823, 0.016359802335500717, 0.04691650718450546, 0.023711226880550385, 0.20054228603839874, 0.030896753072738647, 0.02654736116528511, 0.012237781658768654, 0.04086274281144142, 0.04241224005818367, 0.03929757699370384, 0.007483404129743576, -0.050515688955783844, -0.1220664381980896, 0.0761030837893486, -0.023305609822273254, -0.12864406406879425, 0.1408872902393341, 0.06322746723890305, -0.11050169169902802, 0.042788371443748474, -0.0316128246486187, -0.087003692984581, 0.02353779785335064, 0.07460378110408783, -0.035474859178066254, -0.06795846670866013, 0.06171479821205139, -0.08057808130979538, 0.003057424910366535, 0.004675150848925114, -0.1274964064359665, 0.018257316201925278, 0.0027285078540444374], "changes": {"1wk": 12.072898084906779}}, {"text": "Codexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week editorial-team@simplywallst.com (Simply Wall St) Sat, Dec 14, 2024, 3:14 PM 4 min read In This Article: CDXS Key Insights Institutions' substantial holdings in Codexis implies that they have significant influence over the company's share price The top 9 shareholders own 52% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company A look at the shareholders of Codexis, Inc. ( NASDAQ:CDXS ) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 59% ownership. Put another way, the group faces the maximum upside potential (or downside risk). And things are looking up for institutional investors after the company gained US$65m in market cap last week. The gains from last week would have further boosted the one-year return to shareholders which currently stand at 92%. Let's delve deeper into each type of owner of Codexis, beginning with the chart below. Check out our latest analysis for Codexis NasdaqGS:CDXS Ownership Breakdown December 14th 2024 What Does The Institutional Ownership Tell Us About Codexis? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Codexis already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Codexis, (below). Of course, keep in mind that there are other factors to consider, too. NasdaqGS:CDXS Earnings and Revenue Growth December 14th 2024 Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. It would appear that 11% of Codexis shares are controlled by hedge funds. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Our data shows that Opaleye Management Inc. is the largest shareholder with 11% of shares outstanding. Casdin Capital, LLC is the second largest shareholder owning 10.0% of common stock, and BlackRock, Inc. holds about 8.5% of the company stock. In addition, we found that Stephen Dilly, the CEO has 0.6% of the shares allocated to their name. We also observed that the top 9 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent. Story Continues Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too. Insider Ownership Of Codexis The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Shareholders would probably be interested to learn that insiders own shares in Codexis, Inc.. It has a market capitalization of just US$458m, and insiders have US$14m worth of shares, in their own names. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying. General Public Ownership The general public, who are usually individual investors, hold a 18% stake in Codexis. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run. Private Equity Ownership With a stake of 10.0%, private equity firms could influence the Codexis board. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public. Next Steps: I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 2 warning signs for Codexis you should be aware of. But ultimately it is the future , not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future . NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2024-12-14T15:14:29", "sentiment": {"score": 0.0670744851231575, "confidence": 0.1372905671596527, "probabilities": {"positive": 0.1372905671596527, "negative": 0.07021608203649521, "neutral": 0.7924932837486267}}, "embedding": [0.014552094042301178, -0.12160477787256241, -0.05537772923707962, -0.06764017790555954, -0.05031445622444153, -0.09005163609981537, -0.01671135425567627, 0.046633780002593994, 0.1578463912010193, 0.054623596370220184, -0.10560327768325806, 0.10137926042079926, -0.018865056335926056, 0.0037727374583482742, -0.15104864537715912, -0.15053625404834747, -0.10928088426589966, 0.03258952870965004, -0.15783162415027618, 0.10624049603939056, -0.07318983972072601, -0.22165077924728394, 0.03665757551789284, -0.07206292450428009, 0.03900213912129402, 0.009651856496930122, -0.11762739717960358, -0.08967773616313934, -0.1014571264386177, -0.059207070618867874, -0.09457621723413467, 0.10712800920009613, 0.04435945674777031, -0.04100620746612549, -0.06539585441350937, 0.02741542086005211, 0.041477810591459274, 0.04199247062206268, 0.07823602855205536, 0.058884650468826294, 0.028898438438773155, 0.10729221999645233, -0.03317328542470932, -0.010644663125276566, -0.11789995431900024, -0.1431511491537094, 0.12952423095703125, 0.06335672736167908, -0.02150678262114525, 0.04244304448366165, -0.14933858811855316, 0.04059050232172012, 0.15098467469215393, -0.06394636631011963, -0.04954586923122406, 0.12906575202941895, -0.06335148960351944, -0.15811073780059814, 0.10936156660318375, -0.048169270157814026, 0.05015627667307854, 0.130131796002388, 0.0009153392165899277, 0.059384580701589584, 0.14506536722183228, 0.04871830344200134, -0.017539573833346367, 0.0883018970489502, -0.12420421838760376, -0.011127715930342674, 0.12119695544242859, -0.092751145362854, -0.06696805357933044, 0.03399224206805229, -0.024674750864505768, 0.13528695702552795, -0.009927751496434212, 0.03893104940652847, 0.06177730858325958, -0.22367320954799652, 0.10565344989299774, 0.16468173265457153, -0.027246275916695595, 0.023072272539138794, 0.019240349531173706, 0.11114072799682617, 0.18478189408779144, 0.014784828759729862, 0.12171138823032379, 0.039328619837760925, 0.20428518950939178, -0.06857645511627197, 0.05484260246157646, -0.09992869198322296, 0.0674067810177803, 0.05798046290874481, 0.09288112819194794, -0.01640060544013977, -0.05494258180260658, 0.0949789434671402, 0.03642471507191658, 0.04500144347548485, -0.048996955156326294, -0.00539565272629261, -0.1072353720664978, -0.09242662787437439, 0.005934736225754023, -0.04119337350130081, 0.02211584523320198, -0.04600529372692108, -0.04957982152700424, 0.09359012544155121, -0.17800872027873993, -0.08920864760875702, -0.008009400218725204, -0.02795526757836342, -0.09887705743312836, 0.07736313343048096, 0.12339663505554199, -0.01666780561208725, 0.052007146179676056, -0.02418302744626999, -0.0901201069355011, 0.02830648422241211, 0.10392813384532928, 0.09563356637954712, -0.1252402663230896, 1.4243416559771686e-32, -0.050794828683137894, 0.0792640745639801, -0.03385110944509506, -0.08959869295358658, -0.048192098736763, -0.14201486110687256, -0.011941025033593178, -0.020892396569252014, -0.1281510889530182, 0.011343033984303474, -0.11483685672283173, 0.15212564170360565, -0.11611288785934448, -0.06731169670820236, 0.04834479093551636, 0.13681098818778992, -0.029320210218429565, 0.020566269755363464, -0.012553475797176361, -0.03207552433013916, 0.07145922631025314, 0.15236812829971313, -0.014442839659750462, -0.07741771638393402, 0.055348411202430725, -0.17519496381282806, -0.20931339263916016, 0.022300343960523605, -0.04700968414545059, 0.06321853399276733, 0.09545642882585526, -0.008928323164582253, -0.04458414763212204, -0.11938966810703278, 0.03388521075248718, 0.010179411619901657, -0.08182321488857269, 0.009845146909356117, 0.0700136125087738, 0.031473997980356216, -0.061114706099033356, 0.11369584500789642, -0.16452652215957642, -0.04412802681326866, 0.01842375472187996, -0.07650288194417953, -0.05072740465402603, -0.05205754563212395, -0.0002538654953241348, 0.008993558585643768, 0.012767856009304523, 0.11591947078704834, 0.06787201762199402, -0.022918730974197388, 0.028669685125350952, -0.0021068421192467213, 0.06415804475545883, -0.10162150859832764, 0.04625707119703293, 0.08232393115758896, -0.024756962433457375, 0.07422686368227005, -0.047881487756967545, 0.10358167439699173, -0.15437686443328857, 0.20910575985908508, 0.03984253481030464, 0.04192023724317551, 0.017407841980457306, 0.04571439325809479, -0.048177577555179596, 0.01963636837899685, 0.031618840992450714, -0.09264661371707916, 0.023857150226831436, -0.062121808528900146, -0.043108876794576645, 0.03508371859788895, 0.021647218614816666, 0.019114119932055473, -0.030981365591287613, 0.017652688547968864, -0.011278457939624786, -0.02249627560377121, 0.0025522541254758835, 0.06547585129737854, 0.011158575303852558, 0.023409849032759666, -0.04013066738843918, 0.09152568876743317, 0.11540333926677704, -0.09765501320362091, -0.04504211246967316, 0.13317321240901947, -0.011644667014479637, -1.3337346983525806e-32, -0.06325361132621765, -0.14726808667182922, 0.014109035953879356, -0.09400159120559692, -0.12483160197734833, -0.06396212428808212, -0.003948862664401531, 0.05171115696430206, -0.06878803670406342, -0.14451493322849274, 0.03832128271460533, 0.06305442005395889, -0.11592425405979156, 0.13485005497932434, -0.06039063632488251, -0.05489448457956314, 0.20936806499958038, -0.07510238885879517, -0.014931682497262955, -0.022103652358055115, 0.11853852868080139, 0.09710821509361267, 0.020574983209371567, 0.14030888676643372, 0.06514639407396317, 0.022822462022304535, -0.02035318687558174, 0.16543704271316528, 0.002401115372776985, -0.16539818048477173, -0.046569377183914185, 0.0766550675034523, -0.08228100091218948, 0.033553920686244965, -0.02104826457798481, -0.018846658989787102, -0.062334973365068436, -0.05123100429773331, -0.10943789780139923, 0.04554766044020653, 0.06867548823356628, 0.09991303086280823, 0.0820743590593338, 0.013911187648773193, 0.07607592642307281, 0.13532453775405884, 0.0958387553691864, 0.06760973483324051, 0.1643412858247757, 0.09337256848812103, 0.06980730593204498, -0.05677078291773796, 0.052989862859249115, 0.1047181636095047, 0.04708639904856682, 0.044297151267528534, 0.014337790198624134, -0.02784094400703907, -0.06967546045780182, 0.056595828384160995, 0.04997800290584564, 0.17727869749069214, -0.06234663724899292, 0.13968320190906525, -0.013530159369111061, 0.015471560880541801, -0.12130654603242874, -0.049199555069208145, -0.08212688565254211, -0.028339672833681107, 0.03700889274477959, -0.18895837664604187, 0.020717859268188477, -0.07029014080762863, -0.026959184557199478, 0.2700550854206085, -0.07434748113155365, -0.14581601321697235, -0.055866554379463196, -0.023454155772924423, -0.04697318375110626, 0.06357075273990631, -0.015964774414896965, -0.005700997076928616, -0.0776129886507988, 0.2508123815059662, 0.022107763215899467, -0.0801200419664383, -0.04907640069723129, 0.03929876536130905, 0.02687883749604225, -0.2488282024860382, -0.026880037039518356, -0.09120871871709824, 0.03286077082157135, -1.001197134087306e-07, -0.008159514516592026, -0.009111467748880386, -0.038319990038871765, -0.02254810929298401, -0.04153690114617348, -0.20097026228904724, 0.14507335424423218, -0.014032743871212006, 0.07145211100578308, 0.02709074318408966, 0.2695286273956299, 0.08836711198091507, -0.12380191683769226, -0.03476601094007492, -0.08095765858888626, 0.024656111374497414, -0.1262052059173584, -0.06909419596195221, -0.10767198354005814, -0.15289101004600525, 0.16272492706775665, -0.013716747984290123, 0.21301494538784027, 0.002290588803589344, 0.029984712600708008, -0.00335323391482234, -0.04035177826881409, -0.010552874766290188, -0.0382707342505455, 0.04105758294463158, 0.03382515162229538, -0.12011905014514923, 0.049362991005182266, 0.06443502753973007, 0.14743420481681824, 0.04025881737470627, -0.051151663064956665, 0.08524641394615173, 0.09500479698181152, 0.037028323858976364, 0.03968905657529831, -0.1071598157286644, -0.004312287084758282, -0.0008442029356956482, -0.007730720564723015, -0.0038925400003790855, -0.12232713401317596, 0.11388973891735077, 0.18767833709716797, -0.2856047749519348, 0.05191817134618759, -0.1258808970451355, -0.021626349538564682, 0.06971198320388794, -0.07268451899290085, -0.00747849652543664, -0.10002589225769043, 0.1681128889322281, -0.19493427872657776, -0.10564978420734406, 0.03406259045004845, -0.18835976719856262, -0.0194208025932312, 0.09661845862865448], "changes": {"1wk": -5.882351441216902, "1mo": -21.746884812719873}}, {"text": "Codexis Announces Appointment of Raymond De Vr\u00e9, PhD, to Board of Directors Codexis, Inc. Wed, Nov 13, 2024, 12:05 AM 4 min read In This Article: CDXS Codexis, Inc. REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Raymond De Vr\u00e9, PhD, to the Company\u2019s Board of Directors. \u201cWe are thrilled to have Raymond join the Codexis Board of Directors. He will be an invaluable resource to Codexis,\u201d said Stephen Dilly, MBBS, PhD, Chairman and Chief Executive Officer at Codexis. \u201cRaymond brings a deep understanding of the commercial and regulatory landscape as well as direct experience in oligonucleotide manufacturing.\u201d \u201cCodexis and its ECO Synthesis platform represent the next generation of innovation for oligonucleotide development and manufacturing. I\u2019m excited to partner with the rest of the Board and the executive team as we build a strong and sustainable business on the foundation of this unique technology platform,\u201d said Dr. De Vr\u00e9. Dr. De Vr\u00e9 brings over 20 years of executive-level experience to Codexis. He currently serves as Managing Director at RADV Advisory, an independent strategic and operational advisory company focused on investments in the global healthcare and contract development and manufacturing organization (CDMO) space. Prior to founding RADV Advisory, he was the Chief Executive Officer of PolyPeptide Group, a CDMO focused on peptide- and oligonucleotide-based therapies for pharmaceutical and biotech companies globally. Prior to PolyPeptide, Dr. De Vr\u00e9 held multiple senior leadership roles at Dr. Reddy\u2019s Laboratories, including Senior Vice President, Head of Biologics, and served as a member of the Management Council. Earlier in his career, he was a Partner at McKinsey & Company, working mostly in the pharmaceutical and biotech practice. Dr. De Vr\u00e9 holds a PhD in Applied Physics from Stanford University and a master\u2019s degree in engineering from Universit\u00e9 Libre de Bruxelles. About Codexis Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver \u00ae technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis\u2122 manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis\u2019 unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com . Story Continues Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as \u201caim,\u201d \u201canticipate,\u201d \u201cassume,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cdesign,\u201d \u201cdue,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cgoal,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cobjective,\u201d \u201cplan,\u201d \u201cpositioned,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201csuggest,\u201d \u201ctarget,\u201d \u201con track,\u201d \u201cwill,\u201d \u201cwould\u201d and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management, including but not limited to statements regarding the potential of the ECO Synthesis\u2122 platform, and it providing an opportunity for Codexis to efficiently capture meaningful market share; expectations regarding Codexis meeting its technical and commercial milestones regarding the ECO Synthesis\u2122 platform; and expectations regarding the potential of and future demand for RNAi therapeutics, and whether Codexis will be able to capitalize on such demand. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Codexis\u2019 control and that could materially affect actual results. Factors that could materially affect actual results include, among others: Codexis\u2019 dependence on its licensees and collaborators; if any of its collaborators terminate their development programs under their respective license agreements with Codexis; Codexis may need additional capital in the future in order to expand its business; if Codexis is unable to successfully develop and commercialize new technology such as its ECO Synthesis\u2122 platform and its dsRNA ligase; Codexis dependence on a limited number of products and customers, and potential adverse effects to Codexis\u2019 business if its customers\u2019 products are not received well in the markets; if competitors and potential competitors who have greater resources and experience than Codexis develop products and technologies that make Codexis\u2019 products and technologies obsolete; if Codexis is unable to accurately forecast financial and operational performance; and market and economic conditions may negatively impact Codexis business, financial condition and share price. Additional information about factors that could materially affect actual results can be found in Codexis\u2019 Annual Report on Form 10-K filed with the Securities and Exchange Commission (\u201cSEC\u201d) on February 28, 2024 and in Codexis\u2019 Quarterly Report on Form 10-Q filed with the SEC on October 31, 2024, including under the caption \u201cRisk Factors,\u201d and in Codexis\u2019 other periodic reports filed with the SEC. Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. For More Information Investor Contact Carrie McKim (336) 608-9706 ir@codexis.com Media Contact Lauren Musto (650) 421-8205 media@codexis.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2024-11-13T00:05:00", "sentiment": {"score": 0.13553732819855213, "confidence": 0.1452452689409256, "probabilities": {"positive": 0.1452452689409256, "negative": 0.009707940742373466, "neutral": 0.8450468182563782}}, "embedding": [-0.11871106177568436, -0.11823935806751251, -0.11847827583551407, -0.16332417726516724, -0.013239460065960884, -0.12897242605686188, -0.01022602804005146, 0.1523633897304535, 0.13775035738945007, 0.04802030324935913, -0.20015878975391388, 0.08497931808233261, -0.03991038352251053, 0.05269581079483032, -0.0740714743733406, -0.08281837403774261, -0.08344551920890808, 0.09419954568147659, -0.14103816449642181, 0.010674817487597466, 0.06790520250797272, 0.04130092263221741, 0.0008123194565996528, -0.07809662818908691, -0.10000811517238617, 0.105805903673172, -0.060203373432159424, -0.14077234268188477, -0.1280612349510193, -0.09219872951507568, 0.03612793982028961, 0.13311082124710083, 0.04926462098956108, -0.11415832489728928, 0.0761922150850296, 0.11900290846824646, 0.014476452022790909, -0.019295066595077515, -0.10801258683204651, 0.014001747593283653, 0.002283307723701, 0.042562127113342285, -0.1659252643585205, 0.043267231434583664, -0.13510863482952118, -0.16467732191085815, 0.02785804308950901, -0.09240005165338516, -0.013251452706754208, -0.05319502204656601, -0.19660606980323792, -0.07485955208539963, 0.096125528216362, -0.09316018223762512, -0.08281804621219635, 0.11934798955917358, 0.008977092802524567, -0.2128138393163681, 0.02076730690896511, -0.1015745997428894, 0.06442081928253174, 0.030672073364257812, 0.006477445363998413, 0.14875167608261108, 0.03271804377436638, 0.06401482969522476, -0.019139792770147324, -0.008513360284268856, -0.09325608611106873, -0.12659405171871185, -0.08756685256958008, 0.01345493271946907, -0.010418224148452282, 0.13361699879169464, 0.11729152500629425, 0.07754215598106384, 0.07586899399757385, 0.04461195692420006, 0.11945124715566635, -0.1547395884990692, 0.1504146009683609, 0.07920287549495697, -0.009347367100417614, 0.08915650844573975, -0.04740998148918152, 0.19722560048103333, 0.09039325267076492, 0.11262987554073334, 0.10378248989582062, -0.015899186953902245, 0.10711785405874252, -0.025285014882683754, 0.07632961869239807, -0.11475565284490585, -0.07306467741727829, -0.03175703436136246, 0.1825341284275055, -0.00296221487224102, 0.036700088530778885, 0.08430173993110657, -0.09324805438518524, 0.035155147314071655, -0.0067447153851389885, 0.020332882180809975, -0.13581466674804688, -0.08115319907665253, -0.021023765206336975, 0.03795018419623375, 0.07499540597200394, -0.04036097228527069, -0.08656548708677292, 0.04100513458251953, 0.002353707328438759, -0.04459436237812042, -0.016244633123278618, 0.03960976377129555, -0.06538565456867218, 0.0712999477982521, 0.13381557166576385, -0.03421551361680031, 0.06139908358454704, -0.0027145505882799625, -0.12791094183921814, 0.059009380638599396, 0.06946951895952225, 0.08963698148727417, 0.001233711838722229, 7.355662512426187e-33, -0.03291025385260582, 0.12410926818847656, 0.0872182697057724, 0.03413774445652962, 0.06168707460165024, -0.060410212725400925, 0.008634410798549652, -0.0023109358735382557, -0.15722176432609558, -0.01082537043839693, -0.09654036164283752, 0.026768844574689865, -0.07751278579235077, 0.19121676683425903, -0.022100582718849182, 0.13498623669147491, -0.021881062537431717, 0.017573272809386253, -0.06015845388174057, -0.06361178308725357, 0.04600068926811218, 0.022612007334828377, -0.0262803565710783, 0.18183106184005737, 0.05245432257652283, 0.04394175112247467, -0.08514800667762756, 0.02852797880768776, 0.10638833045959473, 0.021105457097291946, -0.09442125260829926, 0.05700554698705673, -0.07240365445613861, -0.06824205815792084, 0.03424299135804176, 0.011406656354665756, -0.09633156657218933, -0.11137005686759949, 0.04435933008790016, 0.05042152479290962, -0.04370180144906044, 0.13161024451255798, -0.11167031526565552, -0.0493660569190979, 0.06676233559846878, -0.04154696688055992, 0.07261545211076736, 0.044742316007614136, 0.0935434103012085, -0.0455867201089859, -0.08020279556512833, 0.10339289903640747, 0.18158762156963348, -0.05812517926096916, 0.05333799496293068, -0.009708469733595848, 0.0009399214759469032, -0.06605560332536697, 0.0803995355963707, 0.18524450063705444, -0.1301468014717102, 0.09634317457675934, -0.06048737093806267, 0.13087280094623566, -0.08101202547550201, 0.04126456379890442, 0.02901836484670639, -0.1501663327217102, 0.15787431597709656, 0.000838075764477253, -0.11114810407161713, -0.027457308024168015, 0.15322792530059814, -0.011056140065193176, 0.03876078501343727, -0.03994787484407425, 0.0027690259739756584, -0.01420574076473713, -0.05982670933008194, -0.009264914318919182, -0.10567620396614075, 0.16898903250694275, -0.16050361096858978, 0.0006415918469429016, 0.06213253736495972, -0.07603633403778076, -0.05032176524400711, -0.0008528088219463825, -0.07289610058069229, 0.10313533991575241, 0.041195303201675415, -0.13747219741344452, -0.055037081241607666, 0.07861903309822083, 0.021829163655638695, -8.695251466519451e-33, -0.023733321577310562, -0.14588883519172668, -0.0611138716340065, -0.05841008201241493, -0.058620743453502655, -0.025346023961901665, -0.04681065306067467, 0.04481171444058418, 0.1314774453639984, -0.21162903308868408, 0.07733198255300522, 0.10969186574220657, -0.0250018872320652, 0.05410725623369217, -0.13391569256782532, 0.07551852613687515, -0.012751269154250622, -0.08730736374855042, -0.09842046350240707, -0.006041818298399448, 0.09644946455955505, 0.18400007486343384, 0.04235977306962013, 0.023993412032723427, 0.14645788073539734, 0.015239795669913292, 0.07901664078235626, 0.17315059900283813, 0.00042948871850967407, -0.09629691392183304, -0.005776340141892433, 0.056244827806949615, -0.14278708398342133, 0.0034556875471025705, -0.028428196907043457, 0.019091108813881874, -0.006060042418539524, -0.04919514060020447, 0.031004000455141068, -0.03541027009487152, 0.08347933739423752, -0.024219442158937454, -0.024808425456285477, -0.0030310042202472687, 0.0353509783744812, 0.08487346768379211, 0.010336646810173988, -0.008101843297481537, 0.10002540051937103, -0.013082826510071754, -0.026402616873383522, -0.01665598340332508, -0.08586279302835464, -0.055248890072107315, 0.06276925653219223, -0.033346012234687805, 0.0049545615911483765, 0.001591363688930869, -0.009204491041600704, -0.08139154314994812, 0.1151479110121727, 0.09898949414491653, 0.18805745244026184, 0.07964646816253662, 0.06356796622276306, 0.08329251408576965, 0.0011538788676261902, 0.06713461130857468, -0.016169188544154167, -0.08614948391914368, -0.04248502478003502, -0.03664279729127884, 0.016542375087738037, 0.0008987961336970329, 0.04115333780646324, 0.0019912105053663254, -0.24519063532352448, -0.18122363090515137, -0.16361930966377258, -0.022344280034303665, -0.12390874326229095, -0.009229094721376896, -0.04146704077720642, 0.002233387902379036, 0.004616817459464073, 0.18447555601596832, 0.07731129229068756, -0.06803613901138306, -0.05705193430185318, -0.003396345302462578, -0.058111757040023804, -0.12825605273246765, -0.0652824342250824, 0.1627224236726761, 0.057710200548172, -1.0018690943525144e-07, 0.13174191117286682, 0.035855330526828766, -0.06762632727622986, -0.15262733399868011, -0.05851186066865921, -0.11158792674541473, 0.06686260551214218, 0.03850352019071579, 0.03819021210074425, 0.11947473138570786, 0.12236243486404419, 0.14603333175182343, -0.0076600369065999985, 0.08974222093820572, 0.08664537966251373, 0.2196788787841797, -0.09755697846412659, -0.007608040235936642, -0.1644424945116043, -0.14723026752471924, 0.11050674319267273, 0.12754468619823456, 0.017916880548000336, 0.014248233288526535, 0.07226398587226868, -0.1761484146118164, 0.023543108254671097, -0.04997137188911438, 0.018204480409622192, -0.05151812732219696, 0.019667763262987137, -0.01592855527997017, 0.005412088707089424, 0.09767159074544907, 0.10911892354488373, -0.14179182052612305, -0.08170244097709656, -0.00023230630904436111, 0.014334520325064659, -0.02473316714167595, -0.03834738954901695, -0.002066065324470401, -0.09861922264099121, 0.04884044826030731, -0.07515309005975723, -0.01867602951824665, -0.09584008157253265, 0.09800644218921661, 0.026093192398548126, -0.12931618094444275, -0.05212998390197754, -0.023610081523656845, -0.01721150241792202, -0.018466006964445114, -0.08590878546237946, 0.06574234366416931, -0.034718360751867294, -0.024738900363445282, -0.04996923729777336, -0.09918230772018433, -0.025995148345828056, -0.15253794193267822, 0.2165365219116211, -0.00886072963476181], "changes": {"1wk": 5.721393536436705, "1mo": 40.04975475505694}}, {"text": "Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics Codexis, Inc. Fri, Nov 15, 2024, 12:05 AM 8 min read In This Article: CDXS Codexis, Inc. \u2014Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset\u2014 \u2014Joint poster with Bachem demonstrates superiority of Company\u2019s double-stranded RNA ligases compared to wild-type enzymes\u2014 \u2014Management to host conference call today at 4:30 pm EST to discuss data\u2014 REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced data from three presentations at the TIDES Europe annual meeting being held November 12-14, 2024, in Hamburg, Germany. The data demonstrate the Company\u2019s rapid advancement of its Enzyme Catalyzed Oligonucleotide (ECO) Synthesis\u2122 manufacturing platform and establish Codexis\u2019 position at the forefront of enzymatic synthesis technology to enable to ongoing expansion of RNAi therapeutics. Codexis Demonstrates First-ever Enzymatic Synthesis of Approved siRNA Therapeutic During an oral Spotlight Presentation, Codexis unveiled the successful end-to-end enzymatic synthesis of an entire approved siRNA therapeutic asset, inclisiran. Codexis enzymatically synthesized the full-length sense and antisense strands of the molecule, including the enzymatic incorporation of a tissue-targeting moiety to the sense strand. To date, this process has only been completed utilizing phosphoramidite chemistry, a process that involves the use of harsh chemical conditions and vast amounts of toxic organic solvents. By contrast, Codexis\u2019 ECO Synthesis manufacturing platform operates under milder, aqueous conditions, that improves product quality and dramatically decreases chemical waste production. In addition to this fully enzymatic route of synthesis, the Company demonstrated similar outcomes utilizing three routes of enzymatic ligation to produce the siRNA therapeutic asset, combining oligonucleotide fragments made by sequential enzymatic synthesis and traditional phosphoramidite chemistry. Key data from the presentation include: Achieved incorporation efficiency of >98% during sequential enzymatic oligo synthesis Successfully attached the tri-GalNAc tissue-targeting moiety by enzymatic ligation Obtained full-length oligonucleotides of equal quality and yields, using ligation of short fragments made with enzymes or by traditional phosphoramidite chemistry Now that Codexis has successfully achieved this unprecedented milestone, the Company will continue to optimize its process for robustness, scaled-up quantities and improved purity with the goal of providing customers with siRNA material of comparable or better quality to phosphoramidite chemistry. The Company anticipates ramping up manufacturing of siRNA in quantities for preclinical testing following the successful build out of its ECO Synthesis Innovation Lab at the end of this year. Story Continues Codexis Double-stranded RNA Ligase Demonstrates Superior Performance to Wild-type Enzymes Two additional presentations focused on results of direct comparisons of Codexis\u2019 engineered double-stranded RNA (dsRNA) ligases and wild-type (WT) enzymes when used to combine short oligonucleotide fragments to synthesize full-length siRNA therapeutic compounds. In a joint poster with Bachem, one of the world\u2019s leading CDMOs in oligonucleotide manufacturing, the data provided compelling external validation of the superior performance of Codexis ligases over existing wild-type enzymes in use today. Codexis enzymes demonstrated superior performance over wild-type enzymes across both volumetric productivity and substrate versatility. These dsRNA ligases outperformed on multiple substrate designs and enabled a higher conversion rate of oligonucleotide fragments into siRNA at increased concentrations of raw materials. In a separate TIDES Talk presentation, Codexis demonstrated improved performance of its dsRNA ligase over WT enzymes based on real customer case studies executed through the Company\u2019s RNA Ligase Screening and Optimization Services, launched in May 2024. Codexis\u2019 engineered ligases delivered robust, in-process performance, including higher substrate loading, faster reaction times and improved conversation at elevated temperatures. These data demonstrate the Company\u2019s ability to accelerate delivery of lead ligase variants to customers and optimize process conditions for a customer\u2019s specific asset. The slide decks from both presentations as well as the joint poster with Bachem are now available in the Investor Relations section the Codexis corporate website, www.codexis.com/investors . Conference Call and Webcast Codexis management will host a conference call beginning at 4:30 pm Eastern Time on Thursday, November 14, 2024, to discuss the data presented during the conference. The live call can be accessed by dialing 877-705-2976 (domestic) or 201-689-8798 (international). A live webcast to accompany the conference call can be accessed on the Codexis Investor Relations website , where a replay will be available for 90 days. A telephone replay of the call will be available for 48 hours by dialing 877-660-6853 (domestic) or 201-612-7415 (international), access ID #13726635. About RNAi Therapeutics Manufacturing Ribonucleic acid (RNA) as a therapeutic modality has gained tremendous traction in recent years with the growing number of messenger RNA (mRNA) vaccines and small interfering RNA (siRNA) candidates advancing in clinical studies. However, large-scale production of RNA interference (RNAi) therapeutics using traditional chemical synthesis faces complex challenges in nucleic acid quality and quantity, as well as overall economics. With over 450 RNAi therapies currently in clinical development, including more than 40 assets in Phase 2 and Phase 3 clinical trials targeting disease indications impacting millions of patients, RNAi therapeutic demand is projected to outpace current production capabilities by the end of the decade. About the ECO Synthesis Manufacturing Platform Codexis\u2019 proprietary Enzyme Catalyzed Oligonucleotide (ECO) Synthesis\u2122 manufacturing platform is being designed to address scalability and cost limitations by potentially enabling the commercial-scale manufacture of RNAi therapeutics through an enzymatic route. The Company presented groundbreaking data at the TIDES USA 2024 annual meeting demonstrating the enzymatic synthesis of a full-length sense strand of the oligonucleotide lumasiran, a commercially available siRNA therapeutic, as well as shorter sense strand fragments of a second siRNA therapeutic asset, givosiran. The data demonstrate that Codexis consistently achieved coupling efficiency greater than 98%, which is equivalent to what is seen with phosphoramidite chemistry; executed the enzymatic addition of a conjugation moiety to the lumasiran strand; and confirmed the lack of notable impurities typically observed in oligonucleotide synthesis via phosphoramidite chemistry. A recording of the presentation, along with slides and the data press release, can be found on the Codexis corporate website . About Codexis Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver \u00ae technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis\u2122 manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis\u2019 unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com . Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as \u201caim,\u201d \u201canticipate,\u201d \u201cassume,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cdesign,\u201d \u201cdue,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cgoal,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cobjective,\u201d \u201cplan,\u201d \u201cpositioned,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201csuggest,\u201d \u201ctarget,\u201d \u201con track,\u201d \u201cwill,\u201d \u201cwould\u201d and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management, including, but not limited to, the ability of an enzymatic oligonucleotide synthesis process to complement, replace or improve upon traditional chemical synthesis; the potential of the Company\u2019s ECO Synthesis\u2122 platform and double-stranded RNA (dsRNA) ligase screening and optimization services to meet customers\u2019 needs and to create value for Codexis and its customers by enabling commercial-scale manufacture of RNAi therapeutics; completion of the ECO Synthesis Innovation Lab by the end of 2024, and other anticipated technical and commercial milestones related to the ECO Synthesis\u2122 platform and the dsRNA ligase program, and public announcements related thereto; ability of the Company to obtain new development collaborators on its ECO Synthesis technology; the potential for the Company\u2019s dsRNA ligases to have improved scalability and reduced manufacturing costs compared to wild types or non-ligation methods; potential details and features of the ECO Synthesis\u2122 platform such as it being scalable and able to reduce manufacturing costs, as well as having higher quality, purity and yield, and improved sustainability than existing methods; and the future demand for RNAi therapeutics. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Codexis\u2019 control and that could materially affect actual results. Factors that could materially affect actual results include, among others: Codexis\u2019 dependence on its licensees and collaborators; if any of its collaborators terminate their development programs under their respective license agreements with Codexis; Codexis may need additional capital in the future in order to expand its business; if Codexis is unable to successfully develop new technology such as its ECO Synthesis\u2122 manufacturing platform and dsRNA ligase; Codexis\u2019 dependence on a limited number of products and customers, and potential adverse effects to Codexis\u2019 business if its customers\u2019 products are not received well in the markets; whether the end markets for Codexis\u2019 customers\u2019 products develop and remain viable; if competitors and potential competitors who have greater resources and experience than Codexis develop products and technologies that make Codexis\u2019 products and technologies obsolete; Codexis\u2019 ability to comply with debt covenants under its loan facility; if Codexis is unable to accurately forecast financial and operational performance; and market and economic conditions may negatively impact Codexis business, financial condition and share price. Additional information about factors that could materially affect actual results can be found in Codexis\u2019 Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission (\u201cSEC\u201d) on February 28, 2024 and in Codexis\u2019 Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 filed with the SEC on October 31, 2024, including under the caption \u201cRisk Factors,\u201d and in Codexis\u2019 other periodic reports filed with the SEC. Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. For More Information Investor Contact Carrie McKim (336) 608-9706 ir@codexis.com Media Contact Lauren Musto (650) 421-8205 media@codexis.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2024-11-15T00:05:00", "sentiment": {"score": 0.8677585478872061, "confidence": 0.8786927461624146, "probabilities": {"positive": 0.8786927461624146, "negative": 0.010934198275208473, "neutral": 0.11037308722734451}}, "embedding": [-0.050897855311632156, -0.1453702598810196, -0.11271342635154724, -0.19166608154773712, -0.0036095352843403816, -0.0559132844209671, -0.26180317997932434, 0.1115109771490097, 0.013658178970217705, 0.17977863550186157, -0.13150247931480408, 0.01553899236023426, -0.018303947523236275, 0.045957617461681366, -0.12271948158740997, 0.017408624291419983, -0.2366107702255249, 0.05977343022823334, -0.11677107959985733, 0.05219597741961479, 0.1781076341867447, 0.07936906814575195, 0.05789877474308014, 0.0013860426843166351, -0.052598774433135986, 0.030658408999443054, 0.0670531615614891, -0.19824814796447754, -0.1951669454574585, -0.09652596712112427, 7.80811533331871e-05, 0.006065405905246735, 0.09961685538291931, -0.171321839094162, 0.05126779153943062, 0.06972411274909973, 0.019142240285873413, -0.0869441106915474, -0.010023020207881927, -0.09716924279928207, 0.03910355269908905, 0.06447014212608337, -0.1187971904873848, -0.021755684167146683, -0.08531015366315842, -0.1500096619129181, -0.061278995126485825, 0.0201297365128994, 0.027518365532159805, 0.10461871325969696, -0.08005943894386292, -0.09101518988609314, 0.01962149515748024, -0.04833821952342987, 0.031540144234895706, 0.1855151355266571, -0.09847304224967957, -0.14924085140228271, 0.02870011143386364, 0.023683402687311172, 0.0788155347108841, -0.04864038899540901, -0.025484271347522736, 0.0010252706706523895, 0.051791779696941376, -0.020596617832779884, 0.10070179402828217, -0.04590354859828949, -0.032925836741924286, -0.06270082294940948, -0.04010019451379776, -0.1435995250940323, 0.004276258870959282, 0.17520833015441895, -0.01310045551508665, 0.10525573045015335, 0.2136450856924057, 0.058022186160087585, 0.03297145664691925, -0.025045445188879967, 0.005848751403391361, -0.01370877306908369, 0.10111939162015915, 0.13706621527671814, 0.022574342787265778, 0.2118736207485199, -0.04703406244516373, 0.12782035768032074, 0.20280233025550842, -0.02492501027882099, 0.08151376247406006, 0.0040183477103710175, 0.056113846600055695, -0.1533105969429016, 0.009956266731023788, 0.010437225922942162, 0.1417384147644043, 0.09694613516330719, 0.1322949230670929, -0.10542622953653336, 0.04428519308567047, 0.03344157338142395, -0.14076203107833862, -0.17424225807189941, -0.016634389758110046, -0.014311665669083595, -0.0007080323994159698, 0.07725780457258224, 0.09102633595466614, 0.028965376317501068, -0.023358633741736412, 0.01688281074166298, 0.08726519346237183, -0.16643615067005157, -0.21619118750095367, 0.14260104298591614, -0.04191961511969566, -0.0022685127332806587, 0.11669401824474335, 0.029734862968325615, 0.06580421328544617, 0.04505322501063347, -0.12128584086894989, 0.10112839937210083, -0.04771577566862106, 0.0731431394815445, 0.030617468059062958, 8.902466875998434e-33, 0.006810443475842476, 0.08843459188938141, -0.0125619787722826, 0.047653913497924805, 0.1282777190208435, -0.07865453511476517, 0.043511249125003815, 0.09244430810213089, -0.2060299813747406, -0.11431756615638733, -0.05965476855635643, 0.019639071077108383, -0.134179025888443, 0.07795041799545288, -0.0014435779303312302, 0.0662265345454216, 0.08551651984453201, 0.03649761527776718, -0.12231007218360901, -0.01644711010158062, 0.0035577774979174137, 0.04643040522933006, 0.04008021950721741, 0.14786013960838318, 0.038528189063072205, 0.0772564709186554, -0.007621237076818943, -0.018385767936706543, 0.19357192516326904, -0.038256630301475525, -0.12196743488311768, -0.03238501027226448, 0.021054130047559738, -0.13014498353004456, -0.026349028572440147, -0.12046933174133301, -0.10053111612796783, -0.08632819354534149, 0.04888024181127548, 0.16657224297523499, 0.06278018653392792, 0.03826473280787468, -0.156366229057312, -0.022476885467767715, 0.071332648396492, -0.027216730639338493, -0.037936385720968246, 0.07309544086456299, -0.0015448760241270065, 0.015741242095828056, -0.03587557375431061, 0.07009441405534744, 0.14438152313232422, -0.004648690577596426, -0.02843455970287323, 0.008131485432386398, -0.10817338526248932, -0.15264397859573364, 0.1585153341293335, 0.09504908323287964, -0.10553888976573944, 0.07198312878608704, 0.0298675075173378, 0.17032305896282196, -0.055835142731666565, -0.022067712619900703, -0.01605835184454918, -0.10406319051980972, -0.04105842486023903, 0.16601446270942688, -0.07181853801012039, 0.007857120595872402, 0.16325139999389648, 0.03244335204362869, 0.11996175348758698, -0.06465261429548264, 0.016510821878910065, -0.02206944301724434, -0.0007280856370925903, 0.08008633553981781, 0.06030573695898056, 0.27330541610717773, -0.21112200617790222, 0.09915250539779663, 0.08190993219614029, -0.14221355319023132, -0.042681753635406494, 0.022507455199956894, -0.07498109340667725, 0.12965869903564453, 0.10262682288885117, -0.15604671835899353, -0.14146433770656586, 0.05759114772081375, -0.02919432893395424, -1.0419495232980383e-32, 0.09051228314638138, -0.14839541912078857, -0.06977598369121552, -0.09148931503295898, -0.16525918245315552, 0.14106324315071106, -0.07122884690761566, -0.07175961881875992, 0.21392826735973358, -0.16946059465408325, 0.06223520264029503, 0.0029914621263742447, -0.02447662502527237, -0.03966987133026123, -0.1980789303779602, 0.030516518279910088, -0.027561189606785774, 0.09565500915050507, -0.15903456509113312, 0.07681693136692047, 0.15740537643432617, 0.19408319890499115, 0.007399654481559992, -0.02533188834786415, 0.16427572071552277, -0.10694770514965057, 0.02895590104162693, 0.21404823660850525, 0.0133134126663208, 0.04239869862794876, 0.01234561949968338, 0.022096872329711914, -0.22316360473632812, -0.03868972510099411, -0.05300676077604294, 0.1517701894044876, 0.052253130823373795, -0.05862867832183838, 0.11873405426740646, -0.06711231172084808, -0.0323544442653656, 0.04518292844295502, -0.1325971484184265, 0.03309820964932442, -0.017469286918640137, 0.05318524315953255, -0.10888851433992386, -0.021062251180410385, 0.05865619331598282, -0.03414783999323845, 0.08504707366228104, -0.014726810157299042, -0.1014259085059166, -0.018331686034798622, 0.044453974813222885, -0.1293036937713623, -0.044615570455789566, -0.045064643025398254, 0.06128167733550072, -0.10498905181884766, -0.0009138882160186768, -0.03664904087781906, 0.08383260667324066, -0.03220045566558838, 0.020498201251029968, 0.2281010001897812, 0.03969375416636467, 0.09945753216743469, 0.03811097890138626, -0.07509143650531769, -0.1193852573633194, 0.034158460795879364, 0.16129136085510254, 0.13360658288002014, 0.09854152053594589, 0.08629259467124939, -0.17581956088542938, -0.25869321823120117, -0.16292259097099304, -0.08065268397331238, -0.0016675963997840881, -0.005038090981543064, -0.009766065515577793, -0.06490552425384521, 0.12986263632774353, 0.1385570466518402, 0.1457490175962448, 0.1881563365459442, -0.137130469083786, 0.12927678227424622, 0.0013400856405496597, -0.105307936668396, -0.06916594505310059, 0.16684335470199585, 0.13404572010040283, -1.0034507624823163e-07, 0.1817341446876526, -0.04155395179986954, -0.10478713363409042, -0.17669133841991425, -0.1160188838839531, 0.022951483726501465, 0.09457089006900787, 0.008039169944822788, 0.03150896355509758, -0.065290167927742, 0.03981323167681694, 0.11112707853317261, -0.028859540820121765, 0.06876306980848312, 0.03877067193388939, 0.060799356549978256, -0.13197284936904907, 0.022130301222205162, -0.06756078451871872, 0.0362946055829525, 0.010590698570013046, 0.19036418199539185, -0.13359075784683228, -0.016920868307352066, 0.02331545390188694, -0.12334312498569489, 0.05950646102428436, 0.04527690261602402, -0.06403447687625885, -0.14722684025764465, -0.00543716736137867, -0.04498807340860367, -0.018988806754350662, 0.11238408833742142, -0.09292492270469666, -0.11274461448192596, 0.013049444183707237, 0.054017454385757446, -0.05145811289548874, 0.05498114228248596, 0.01702618971467018, -0.012241801247000694, -0.18398715555667877, -0.008673209697008133, -0.08520270884037018, -0.05349785089492798, -0.07394464313983917, 0.12056604772806168, 0.040553558617830276, 0.012092597782611847, -0.0008432399481534958, -0.049167994409799576, 0.09001395106315613, -0.1933889240026474, -0.07911653816699982, 0.03184331953525543, -0.049003854393959045, -0.08504815399646759, -0.046119481325149536, -0.10696740448474884, 0.013034602627158165, -0.1575489640235901, 0.24233046174049377, -0.09391067177057266], "changes": {"1wk": 15.775398734354336, "1mo": 47.860967799658525}}, {"text": "Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics Codexis, Inc. Tue, Nov 12, 2024, 12:05 AM 7 min read In This Article: CDXS Codexis, Inc. \u2014Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset\u2014 \u2014Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-type enzymes\u2014 \u2014Management to host conference call on Thursday, November 14 to discuss data\u2014 REDWOOD CITY, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will demonstrate real-world application of its enzymatic synthesis platform via three presentations at the upcoming TIDES Europe annual meeting, being held November 12-14, 2024, in Hamburg, Germany. Codexis management will hold an investor conference call at 4:30 pm Eastern Time on November 14, 2024, to review and discuss the data presented. In a joint poster with Bachem, one of the world\u2019s leading CDMOs in siRNA manufacturing, Codexis will feature data demonstrating the superiority of its double-stranded RNA ligase variants compared to wild-type enzymes. The company will also participate in two oral presentations. On Wednesday, November 13, 2024, a TIDES Talk will showcase the extensive capabilities of Codexis\u2019 RNA Ligase Screening & Optimization Services, including data from real customer case studies. On Thursday, November 14, 2024, a Spotlight Presentation will showcase the abilities of the Company\u2019s proprietary Enzyme Catalyzed Oligonucleotide (ECO) Synthesis\u2122 manufacturing platform utilizing various combinations of sequential enzymatic synthesis, traditional phosphoramidite chemistry and enzymatic ligation to produce a commercially available siRNA therapeutic. This public demonstration will further highlight the flexibility and broad applicability of the ECO Synthesis\u2122 platform to the manufacture of siRNA therapeutics. Attendees of the conference may visit with the Codexis team at Booth #709 in the exhibition hall. Appointments may be made in advance by contacting the business development team . Presentation Details Spotlight Presentation: Process Development for Enzymatic Synthesis of RNAi Therapeutics Date: Thursday, November 14, 2024 Time: 1:25 pm \u2013 1:55 pm Central European Time (CET) Codexis Speaker: Derek Gauntlett, Senior Director, ECO Synthesis Process Development TIDES Talk: RNA Synthesis Using Ligation for Improved Scalability and Reduced Manufacturing Cost Date: Wednesday, November 13, 2024 Time: 3:55 pm \u2013 4:10 pm Central European Time (CET) Codexis Speaker: Mathew Miller, PhD, Director, Life Science & RNA Technology Story Continues Poster Presentation: Engineered dsRNA ligases can efficiently scale siRNA manufacturing Time: Duration of the Conference Location: Poster & Exhibit Hall Oral presentations will take place at the Hamburg Conference Center in Hamburg, Germany. Conference Call and Webcast Codexis management will host a conference call beginning at 4:30 pm Eastern Time on Thursday, November 14, 2024, to discuss the data presented during the conference. The live call can be accessed by dialing 877-705-2976 (domestic) or 201-689-8798 (international). A live webcast to accompany the conference call can be accessed on the Codexis Investor Relations website , where a replay will be available for 90 days. A telephone replay of the call will be available for 48 hours by dialing 877-660-6853 (domestic) or 201-612-7415 (international), access ID #13726635. About RNAi Therapeutics Manufacturing Ribonucleic acid (RNA) as a therapeutic modality has gained tremendous traction in recent years with the growing number of messenger RNA (mRNA) vaccines and small interfering RNA (siRNA) candidates advancing in clinical studies. However, large-scale production of RNA interference (RNAi) therapeutics using traditional chemical synthesis faces complex challenges in nucleic acid quality and quantity, as well as overall economics. With over 450 RNAi therapies currently in clinical development, including more than 40 assets in Phase 2 and Phase 3 clinical trials targeting disease indications impacting millions of patients, RNAi therapeutic demand is projected to outpace current production capabilities by the end of the decade. About the ECO Synthesis Manufacturing Platform Codexis\u2019 proprietary Enzyme Catalyzed Oligonucleotide (ECO) Synthesis\u2122 manufacturing platform is being designed to address these scalability and cost limitations by potentially enabling the commercial-scale manufacture of RNAi therapeutics through an enzymatic route. The Company presented groundbreaking data at the TIDES USA 2024 annual meeting demonstrating the enzymatic synthesis of a full-length sense strand of the oligonucleotide lumasiran, a commercially available siRNA therapeutic, as well as shorter sense strand fragments of a second siRNA therapeutic asset, givosiran. The data demonstrate that Codexis consistently achieved coupling efficiency greater than 98%, which is equivalent to what is seen with phosphoramidite chemistry; executed the enzymatic addition of a conjugation moiety to the lumasiran strand; and confirmed the lack of notable impurities typically observed in oligonucleotide synthesis via phosphoramidite chemistry. A recording of the presentation, along with slides and the data press release, can be found on the Codexis corporate website . About Codexis Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver \u00ae technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis\u2122 manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis\u2019 unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com . Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as \u201caim,\u201d \u201canticipate,\u201d \u201cassume,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cdesign,\u201d \u201cdue,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cgoal,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cobjective,\u201d \u201cplan,\u201d \u201cpositioned,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201csuggest,\u201d \u201ctarget,\u201d \u201con track,\u201d \u201cwill,\u201d \u201cwould\u201d and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management, including, but not limited to, the ability of an enzymatic oligonucleotide synthesis process to complement or replace traditional chemical synthesis; the potential of the Company\u2019s ECO Synthesis\u2122 platform and double-stranded RNA (dsRNA) ligase screening and optimization services to create value for Codexis and its customers by enabling commercial-scale manufacture of RNAi therapeutics; other anticipated technical and commercial milestones related to the ECO Synthesis\u2122 platform and the dsRNA ligase program, and public announcements related thereto; the potential for the Company\u2019s dsRNA ligases to have improved scalability and reduced manufacturing costs compared to wild types or non-ligation methods; potential details and features of the ECO Synthesis\u2122 platform such as it being scalable and able to reduce manufacturing costs, as well as having higher purity and yield than existing methods; and the future demand for RNAi therapeutics. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Codexis\u2019 control and that could materially affect actual results. Factors that could materially affect actual results include, among others: Codexis\u2019 dependence on its licensees and collaborators; if any of its collaborators terminate their development programs under their respective license agreements with Codexis; Codexis may need additional capital in the future in order to expand its business; if Codexis is unable to successfully develop new technology such as its ECO Synthesis\u2122 manufacturing platform and dsRNA ligase; Codexis\u2019 dependence on a limited number of products and customers, and potential adverse effects to Codexis\u2019 business if its customers\u2019 products are not received well in the markets; whether the end markets for Codexis\u2019 customers\u2019 products develop and remain viable; if Codexis is unable to develop and commercialize new products for its target markets; whether the end markets for Codexis\u2019 customers\u2019 products develop and remain viable; if competitors and potential competitors who have greater resources and experience than Codexis develop products and technologies that make Codexis\u2019 products and technologies obsolete; Codexis\u2019 ability to comply with debt covenants under its loan facility; if Codexis is unable to accurately forecast financial and operational performance; and market and economic conditions may negatively impact Codexis business, financial condition and share price. Additional information about factors that could materially affect actual results can be found in Codexis\u2019 Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission (\u201cSEC\u201d) on February 28, 2024 and in Codexis\u2019 Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 filed with the SEC on October 31, 2024, including under the caption \u201cRisk Factors,\u201d and in Codexis\u2019 other periodic reports filed with the SEC. Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. For More Information Investor Contact Carrie McKim (336) 608-9706 ir@codexis.com Media Contact Lauren Musto (781) 572-1147 media@codexis.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2024-11-12T00:05:00", "sentiment": {"score": 0.145236911252141, "confidence": 0.1537473052740097, "probabilities": {"positive": 0.1537473052740097, "negative": 0.008510394021868706, "neutral": 0.837742269039154}}, "embedding": [-0.11317538470029831, -0.1531103253364563, -0.08729605376720428, -0.16721194982528687, -0.04060264676809311, -0.09760215878486633, -0.2706058621406555, 0.09571592509746552, -0.06559118628501892, 0.08708849549293518, -0.2113797664642334, 0.004137816373258829, -0.07154498249292374, 0.07774769514799118, -0.10834923386573792, -0.027053365483880043, -0.13693448901176453, 0.004691768437623978, -0.12724299728870392, 0.0373995266854763, 0.11237773299217224, 0.05642809718847275, 0.08384452760219574, -0.011422492563724518, -0.031355854123830795, 0.0056998105719685555, -0.009360662661492825, -0.19370979070663452, -0.15961769223213196, -0.12299798429012299, -0.05022003501653671, 0.09864548593759537, 0.09146726876497269, -0.14522488415241241, 0.07194693386554718, 0.05296976491808891, 0.027797065675258636, -0.07458975911140442, -0.0009451024234294891, -0.09318466484546661, 0.022754285484552383, -0.014191563241183758, -0.1296122819185257, 0.005827322602272034, -0.14228688180446625, -0.1468874216079712, -0.03312759846448898, 0.0019336016848683357, -0.029809802770614624, 0.08098182827234268, -0.15083053708076477, -0.2328803539276123, 0.02297535538673401, -0.061741121113300323, 0.019159331917762756, 0.166501984000206, -0.07987326383590698, -0.15769542753696442, 0.047737594693899155, 0.019663983955979347, 0.08172737807035446, -0.028430510312318802, -0.09187015146017075, 0.07077373564243317, 0.09735125303268433, 0.03862331062555313, 0.10828229784965515, 0.04098134487867355, 0.04793775826692581, -0.16398988664150238, -0.021550653502345085, -0.11187142878770828, -0.006454417947679758, 0.17265817523002625, 0.0362016037106514, 0.0953444391489029, 0.1893279105424881, 0.03101768158376217, 0.118275485932827, -0.10453297197818756, 0.014435519464313984, 0.01028396561741829, 0.036155957728624344, 0.05003124848008156, 0.036535538733005524, 0.1876102089881897, 0.03377660736441612, 0.1517307162284851, 0.1715461015701294, 0.039454229176044464, 0.06470052897930145, -0.002781885676085949, 0.004484772682189941, -0.13075920939445496, -0.07302961498498917, 0.06634144484996796, 0.13307863473892212, 0.03748352825641632, 0.15989531576633453, 0.01114087738096714, 0.03053395450115204, 0.10024335980415344, -0.042401473969221115, -0.15639755129814148, -0.04199577122926712, -0.08450332283973694, -0.009799119085073471, 0.08441993594169617, 0.025172173976898193, -0.007439192850142717, -0.016752542927861214, 0.07404971122741699, 0.13105815649032593, -0.1453118622303009, -0.12921684980392456, 0.12984414398670197, -0.08048052340745926, 0.0035045500844717026, 0.1591625213623047, 0.057796910405159, 0.09248222410678864, -0.0051782140508294106, -0.08114324510097504, 0.06521661579608917, 0.0002680141478776932, 0.10000330209732056, -0.0966762974858284, 9.146818356071802e-33, 0.013214181177318096, 0.05327559635043144, 0.021261630579829216, 0.04287230223417282, 0.12180724740028381, -0.11671140044927597, -0.045518919825553894, 0.0865512266755104, -0.2008172571659088, -0.07661373168230057, -0.11312291771173477, 0.0014837710186839104, -0.14194080233573914, 0.13557587563991547, -0.029700521379709244, 0.020328190177679062, 0.037352047860622406, 0.10505040735006332, -0.18613430857658386, 0.025753380730748177, 0.031473975628614426, -0.010902793146669865, 0.01170987356454134, 0.1222766786813736, 0.06800490617752075, 0.10918255150318146, -0.0033303434029221535, -0.025920681655406952, 0.21610552072525024, 0.04893503338098526, -0.18055127561092377, -0.02589380368590355, -0.04619527608156204, -0.09974906593561172, 0.009775953367352486, -0.047314904630184174, -0.0818774476647377, -0.15918058156967163, 0.015806308016180992, 0.12945671379566193, 0.048259295523166656, 0.07119330018758774, -0.1845325529575348, -0.061615534126758575, 0.1096125990152359, -0.07918324321508408, -0.0285685695707798, 0.05866556614637375, 0.07593626528978348, -0.09579352289438248, 0.006363332271575928, 0.06120797246694565, 0.12657149136066437, -0.02534203790128231, 0.07911734282970428, 0.07628977298736572, -0.05328889936208725, -0.16410335898399353, 0.11388278007507324, 0.1863691806793213, -0.049250517040491104, 0.08155867457389832, 0.009690085425972939, 0.12249144911766052, -0.12144823372364044, -0.008140863850712776, -0.05417965352535248, -0.12849052250385284, -0.05778893828392029, 0.13740026950836182, -0.09288129955530167, -0.006448897998780012, 0.17573751509189606, -0.01548343151807785, 0.14773248136043549, -0.04598075523972511, 0.09376414865255356, 0.004807963036000729, 0.022423159331083298, 0.07284565269947052, 0.000989783788099885, 0.20886020362377167, -0.18151798844337463, 0.1220485270023346, 0.096284881234169, -0.10290634632110596, 0.019534889608621597, -0.01518719457089901, -0.11628755927085876, 0.1195569634437561, 0.048284970223903656, -0.10243090987205505, -0.12056871503591537, 0.03402366489171982, 0.04595973342657089, -1.0362912812403553e-32, 0.04012657701969147, -0.133165180683136, -0.0530158132314682, -0.12409502267837524, -0.16310745477676392, 0.09509958326816559, -0.045003581792116165, -0.018857035785913467, 0.1679306924343109, -0.1054309532046318, 0.09080486744642258, 0.03575538843870163, 0.04124424606561661, -0.0343782976269722, -0.13231462240219116, -0.003464754670858383, -0.014067910611629486, -0.02220260724425316, -0.09801111370325089, 0.13455304503440857, 0.14043517410755157, 0.22487874329090118, -0.010148603469133377, 0.003630219027400017, 0.12920042872428894, -0.11226946115493774, 0.08901935815811157, 0.2529892027378082, 0.03774217516183853, -0.05281133949756622, -0.04918587952852249, 0.044827669858932495, -0.1879267543554306, 0.03177827596664429, -0.08443131297826767, 0.16177111864089966, 0.11432214081287384, -0.09785658866167068, 0.10685668140649796, -0.06517191231250763, 0.007395785301923752, 0.0521528422832489, -0.15074816346168518, 0.02901437133550644, -0.010377353988587856, 0.08296409249305725, -0.06989674270153046, 0.015749238431453705, 0.12556597590446472, -0.042023926973342896, 0.07751940935850143, -0.03502979874610901, -0.1014605313539505, -0.05983905494213104, -0.01378698367625475, -0.1550789326429367, -0.03910316526889801, -0.07442480325698853, 0.046256162226200104, -0.045713670551776886, -0.05444053187966347, 0.008542247116565704, 0.08592841029167175, -0.05509480834007263, 0.020357634872198105, 0.14858128130435944, 0.0066404566168785095, 0.07183407247066498, -0.01392786018550396, -0.0052797989919781685, -0.042440805584192276, -0.06355063617229462, 0.06458353996276855, 0.06640666723251343, 0.10549801588058472, 0.049571454524993896, -0.17751401662826538, -0.20090235769748688, -0.15564224123954773, -0.0829353928565979, -0.00022502802312374115, 0.07017063349485397, 0.007361629977822304, -0.04172603413462639, 0.180215984582901, 0.1258724331855774, 0.12891866266727448, 0.1765574812889099, -0.08351390063762665, 0.11942015588283539, -0.07478100061416626, -0.06990989297628403, -0.13023042678833008, 0.19438299536705017, 0.15842103958129883, -1.0033539865617058e-07, 0.19428406655788422, 0.008172677829861641, -0.05274508520960808, -0.14032620191574097, -0.09170754253864288, -0.03898531198501587, 0.03380478918552399, 0.02249481901526451, 0.03323457017540932, -0.0087904566898942, 0.08103238046169281, 0.14823384582996368, -0.05070266127586365, 0.05042172595858574, 0.06845368444919586, 0.11726795136928558, -0.17639939486980438, -0.003534993389621377, -0.14034512639045715, -0.08915726095438004, 0.06874001026153564, 0.21022650599479675, -0.004499310627579689, 0.03364338353276253, -0.00823519192636013, -0.13690105080604553, 0.017336178570985794, 0.07190896570682526, -0.033793579787015915, -0.20390969514846802, -0.0014271843247115612, 0.0055852970108389854, 0.003931077197194099, 0.09593139588832855, -0.06920544803142548, -0.10242846608161926, -0.07390713691711426, 0.0712510347366333, 0.005335086956620216, 0.11174353212118149, 0.03494076803326607, -0.10893853008747101, -0.19875073432922363, 0.0007434133440256119, -0.06723693013191223, -0.04358983039855957, -0.09964286535978317, 0.08868425339460373, 0.06419944763183594, 0.003324560821056366, -0.02869773656129837, -0.044071733951568604, 0.0857258141040802, -0.13649579882621765, -0.04197193682193756, 0.18358415365219116, -0.0947057455778122, -0.13153888285160065, -0.03809581324458122, -0.03061559796333313, 0.07692048698663712, -0.14555419981479645, 0.15503327548503876, -0.06238900125026703], "changes": {"1wk": -3.2019674348403777, "1mo": 43.103448883349536}}, {"text": "Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference Codexis, Inc. Wed, Nov 20, 2024, 12:05 AM 1 min read In This Article: CDXS Codexis, Inc. REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS),\u00a0a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Piper Sandler 36 th Annual Healthcare Conference, being held December 3-5, 2024, in New York, New York. Management will participate in a fireside chat on Tuesday, December 3, 2024, at 11:00 am ET. A live webcast of the event will be available in the Investor Relations section of the Company\u2019s website, https://ir.codexis.com . A replay will be archived for 90 days following the event. About Codexis Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver \u00ae technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis\u2122 manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis\u2019 unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com . For More Information Investor Contact Carrie McKim (336) 608-9706 ir@codexis.com Media Contact Lauren Musto (650) 421-8205 media@codexis.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CDXS", "date": "2024-11-20T00:05:00", "sentiment": {"score": 0.15180961694568396, "confidence": 0.1609974056482315, "probabilities": {"positive": 0.1609974056482315, "negative": 0.00918778870254755, "neutral": 0.8298148512840271}}, "embedding": [-0.10622665286064148, -0.14209997653961182, -0.19171136617660522, -0.12246917933225632, 0.056207481771707535, -0.05010899901390076, -0.0888151228427887, 0.08789840340614319, 0.00025650643510743976, -0.0019204610725864768, -0.18666352331638336, 0.06930321455001831, -0.048418812453746796, 0.06997678428888321, -0.13924086093902588, -0.04574446752667427, -0.06827502697706223, 0.03692876920104027, -0.16782507300376892, -0.06227225437760353, 0.03651465103030205, 0.031991761177778244, 0.056505993008613586, -0.013151878491044044, -0.11370722949504852, 0.05241967365145683, -0.08872951567173004, -0.0831032395362854, -0.06778072565793991, -0.08888468891382217, 0.11493650823831558, 0.13838663697242737, 0.07515104115009308, -0.13828402757644653, 0.10568074136972427, 0.06898937374353409, -0.008459396660327911, -0.015995673835277557, -0.07333206385374069, 0.01915093883872032, 0.007169957738369703, -0.004364872816950083, -0.1121639534831047, -0.008496494963765144, -0.13640756905078888, -0.16775982081890106, 0.03258547931909561, -0.05113507807254791, 0.09632688015699387, 0.06983292102813721, -0.19582819938659668, -0.08515523374080658, 0.04757609963417053, -0.05189300701022148, -0.02305934764444828, 0.0785922035574913, -0.0736539214849472, -0.20099516212940216, -0.06777696311473846, -0.14280818402767181, 0.07388105988502502, -0.028784776106476784, 0.01971830427646637, 0.1182013750076294, -0.01461301650851965, 0.10759679228067398, 0.05560769513249397, -0.002991723595187068, 0.046169210225343704, -0.17715846002101898, -0.0805375948548317, -0.04172361642122269, 0.06469816714525223, 0.18025366961956024, 0.07817257195711136, 0.07451462000608444, 0.15133774280548096, -0.018267864361405373, 0.08664210885763168, -0.05699070170521736, 0.008590527810156345, 0.018680771812796593, 0.061073463410139084, 0.13421383500099182, 0.04430100694298744, 0.21771550178527832, 0.06647732853889465, 0.11569776386022568, 0.13943207263946533, 0.04943157732486725, 0.06350389122962952, 0.01631898619234562, -0.04754152148962021, -0.10841281712055206, -0.054238200187683105, -0.05071178078651428, 0.20884178578853607, 0.005645990837365389, 0.04616944119334221, 0.051295988261699677, -0.07872139662504196, 0.0822737067937851, -0.03708801418542862, -0.1580360233783722, -0.09008660167455673, -0.08791834115982056, -0.03184300661087036, 0.13935115933418274, 0.03236853703856468, -0.03025742433965206, -0.036142297089099884, 0.05956126004457474, 0.08209627866744995, -0.07051471620798111, 0.023855775594711304, 0.11320549249649048, -0.044408541172742844, -0.034279994666576385, 0.1079181656241417, 0.05094752460718155, 0.045369379222393036, 0.022966234013438225, -0.09879295527935028, 0.03471733629703522, 0.03678739815950394, 0.06393086165189743, -0.08014419674873352, 8.603822250596462e-33, 0.015252634882926941, 0.08616458624601364, 0.03164702281355858, 0.06320427358150482, 0.10882716625928879, -0.09914160519838333, -0.015487386845052242, 0.021303227171301842, -0.12626704573631287, 0.03321978449821472, -0.10000025480985641, -8.719109609955922e-05, -0.037864964455366135, 0.09014715254306793, -0.0019874649588018656, 0.04203151911497116, -0.03844359144568443, 0.0534641332924366, -0.10257811844348907, -0.02795417048037052, 0.023948047310113907, -0.01954333856701851, -0.049701008945703506, 0.10842755436897278, 0.051457375288009644, 0.1408504843711853, 0.017958497628569603, -0.0012153609422966838, 0.15331868827342987, 0.03349163383245468, -0.061033036559820175, -0.03449571132659912, -0.07754876464605331, -0.11108028143644333, 0.0010986231500282884, 0.042040593922138214, -0.12583298981189728, -0.06349591165781021, 0.008530677296221256, 0.09982841461896896, 0.009885843843221664, 0.11430690437555313, -0.1519128531217575, -0.03682131692767143, 0.13402964174747467, -0.1508968025445938, -0.006329189985990524, 0.13650573790073395, 0.09362047910690308, -0.049966055899858475, -0.012795265763998032, 0.08169034868478775, 0.20529428124427795, -0.05786917358636856, 0.05273197218775749, 0.012645861133933067, -0.04870050773024559, -0.15916945040225983, 0.11143213510513306, 0.19653311371803284, -0.13357962667942047, 0.039767034351825714, -0.06327322125434875, 0.09069325029850006, -0.01943562924861908, -0.02398613467812538, -0.035736847668886185, -0.14769107103347778, 0.06453415006399155, 0.10024962574243546, -0.05124205723404884, 0.02790902554988861, 0.16232427954673767, -0.03638118878006935, 0.08591678738594055, -0.03269798681139946, 0.05473976209759712, -0.06870148330926895, -0.014601835049688816, 0.023125944659113884, -0.1016455739736557, 0.13131825625896454, -0.10814742743968964, 0.0911637470126152, -0.044015731662511826, -0.08541145920753479, -0.057215556502342224, 0.042623743414878845, -0.1132376492023468, 0.10683448612689972, 0.052057113498449326, -0.13735026121139526, -0.07207038998603821, 0.0517541840672493, 0.026308512315154076, -8.142720632491004e-33, 0.06825578957796097, -0.128003790974617, -0.10524621605873108, -0.05594104155898094, -0.06846202909946442, 0.020345011726021767, 0.0023263616021722555, 0.06171336770057678, 0.17573793232440948, -0.09571543335914612, 0.0869872123003006, 0.06041549891233444, -0.027310071513056755, -0.02869369089603424, -0.1201590821146965, 0.039621155709028244, 0.013289147056639194, -0.08027589321136475, -0.024358542636036873, 0.042219024151563644, 0.08706510812044144, 0.2642647624015808, 8.243485353887081e-05, -0.025998393073678017, 0.07908515632152557, 0.015320433303713799, 0.011239458806812763, 0.1979180872440338, 0.06504455208778381, -0.08550345152616501, 0.010971639305353165, 0.015270722098648548, -0.15406937897205353, 0.02852807380259037, -0.009901529178023338, 0.10280914604663849, 0.08097642660140991, -0.05121101438999176, 0.037113387137651443, -0.08026642352342606, 0.1138286367058754, -0.013553406111896038, -0.0992204025387764, 0.07206091284751892, 0.058269523084163666, 0.13960404694080353, -0.07847616821527481, 0.0018450568895787, 0.1376783698797226, 0.02981487475335598, 0.018071603029966354, -0.10439267754554749, -0.13365750014781952, 0.01699003390967846, 0.05789053812623024, -0.02871103025972843, -0.03212601691484451, -0.09587293118238449, -0.0955062210559845, -0.016436772421002388, 0.0025822133757174015, -0.010790631175041199, 0.12534275650978088, 0.05666332319378853, 0.018912961706519127, 0.06703729182481766, 0.01213346142321825, 0.12235806882381439, -0.019184798002243042, -0.0063857464119791985, 0.01608017086982727, 0.005847258027642965, 0.11369743943214417, 0.0662374198436737, 0.08715527504682541, -0.0021965112537145615, -0.12573249638080597, -0.08158985525369644, -0.08700121194124222, -0.051972683519124985, -0.0642789676785469, 0.09858401864767075, -0.10366600751876831, -0.06329856812953949, 0.1140807718038559, 0.1482180804014206, 0.08908360451459885, 0.07823720574378967, -0.061914410442113876, -0.0044928123243153095, -0.03818357363343239, -0.0842508003115654, -0.09273494780063629, 0.09878850728273392, 0.0669904351234436, -9.975193648870118e-08, 0.15158407390117645, 0.010184991173446178, -0.15255582332611084, -0.07260219752788544, -0.14964726567268372, -0.05176568403840065, 0.01904119923710823, 0.019337400794029236, 0.006006824318319559, -0.011688178405165672, 0.1626056581735611, 0.17797090113162994, 0.04705467075109482, 0.05830421298742294, 0.0629505142569542, 0.12901447713375092, -0.1521410346031189, -0.07401306927204132, -0.15708890557289124, -0.25054141879081726, 0.025161854922771454, 0.06053657457232475, 0.020034009590744972, 0.03636612370610237, 6.310579192359e-05, -0.09753280878067017, 0.014255793765187263, 0.000972384528722614, -0.005169018171727657, -0.08626527339220047, -0.07896745949983597, -0.02570524252951145, 0.037442974746227264, 0.07228393852710724, 0.08529260009527206, -0.12336542457342148, -0.11554442346096039, 0.029192224144935608, 0.03701072558760643, 0.06662433594465256, 0.02237830124795437, -0.07844415307044983, -0.20037716627120972, -0.031423043459653854, -0.024372747167944908, -0.08406536281108856, -0.1267339289188385, 0.0315454937517643, 0.04920714348554611, -0.018849389627575874, 0.01251651905477047, -0.03576694801449776, 0.08892332762479782, -0.017357992008328438, -0.08184952288866043, 0.2062966376543045, -0.04873102530837059, -0.14791683852672577, 0.07996892184019089, -0.07322732359170914, -0.006125657353550196, -0.10697706788778305, 0.1049128919839859, -0.015489358454942703], "changes": {"1wk": 7.294116300695083, "1mo": 20.470585542566635}}]